The Investing Fascia–Carotid Sheath Mechanistic Hypothesis of Internal Jugular Vein Outflow Obstruction

1. Introduction: From “Venous Compression” to “Adequacy of Compensation”

The association between cerebral venous outflow obstruction and a range of neurological symptoms has gained increasing support from clinical studies of internal jugular vein (IJV) stenosis. The clinical manifestations of IJV outflow obstruction extend well beyond headache: tinnitus, cerebral tinnitus, headache, dizziness, visual disturbances, sleep disorders, and subjective memory decline constitute its common symptom spectrum. This multisystem, multidomain clinical picture suggests that a single anatomical stenosis is insufficient to fully explain the entire phenotype.

Nevertheless, a persistent gap remains: if stenosis itself were sufficient to cause disease, symptom severity should roughly parallel the anatomical degree of stenosis. Clinical observation, however, is not consistent with this expectation. In the study of 283 patients with nonthrombotic IJV stenosis, the headache group did indeed have a higher obstruction “burden,” but the truly discriminating variable was compensation status: individuals with severe vertebral vein dilation had approximately one-fifth the headache risk of those without such compensation (OR = 0.184); in contrast, a high jugular bulb and severe scalp vein dilation, as markers of obstruction burden, were independently associated with increased headache risk (1). The same stenosis produced markedly different clinical consequences under different backgrounds of collateral compensation and valvular function.

This gap was not identified by the present hypothesis alone. The review by Hui et al. explicitly stated that cognitive impairment is increasingly recognized in patients with cerebral venous congestion, but why some patients develop severe symptoms while others do not remains a mystery; existing cognitive assessment tools are largely borrowed from arterial or neurodegenerative disease paradigms and are insufficiently sensitive to venous cognitive impairment (2). This statement comes from an independent review in the field of venous disease, indicating that “the same venous congestion with markedly different symptom severity” has been formally recognized as an unresolved problem at the field level. The present hypothesis is advanced precisely at this gap: collateral compensation and valvular function—rather than luminal diameter—are the mediating variables closer to clinical reality, and their upstream determinants may be systematically traced to the mechanical state of extrasheath soft tissues.

This gap has likewise been confirmed at the level of independent review in the intracranial pressure dimension: a recent narrative review from a core team in cerebral venous disease explicitly stated that a substantial proportion of patients with imaging-confirmed CVSS/IJVS have normal or only mildly elevated intracranial pressure (<250 mmH₂O), that elevated ICP is “neither a necessary nor a sufficient condition for diagnosis,” and that collateral venous pathways, preserved lymphatic cerebrospinal fluid drainage, and anatomical variants are possible mechanisms by which ICP is maintained within the normal range (3). This suggests that neither stenosis severity nor an ICP threshold is adequate as a single diagnostic anchor; rather, compensation status should be incorporated into the core assessment framework—a position consistent with the present hypothesis, which places “adequacy of compensation” above “stenosis itself.”

The IJV descends within the carotid sheath, in which the vein lies lateral to the artery and the vagus nerve lies posteriorly between them; the fascial investment of the IJV is relatively loose, making it a structure within the sheath that is susceptible to the external mechanical environment (4). This source of soft-tissue compression is not limited to the sternocleidomastoid muscle or the common carotid artery: the anatomical review by Dincă et al. systematically cataloged the anatomical causes of impaired IJV flow and explicitly noted that specific compression of the IJV is not solely due to bony impingement at the styloid process–C1 transverse process; the digastric muscle, omohyoid muscle, sternocleidomastoid muscle, hyoid bone, and tortuous carotid artery can all compress the IJV and lead to elevated intracranial pressure (5). This multi-source spectrum confirms “soft-tissue compression” as a clinical entity independent of bony compression, rather than an ancillary phenomenon of bony etiologies. Unlike bony compression at the C1 transverse process/styloid process, for which standardized bony decompression protocols exist, no validated and widely adopted venous decompression technique is available for compression caused by soft tissue or arteries; isolated case reports have described symptom relief after omohyoid resection, but such interventions remain experimental and unverified in larger cohorts (6–7). The present hypothesis proposes that sclerotic fibrosis of the investing fascia is precisely a candidate upstream mechanism for this recognized but not yet effectively addressed soft-tissue constraint: it does not directly cause luminal stenosis, but rather persistently depletes collateral compensation and valvular function by altering the mechanical boundary conditions around the carotid sheath.

The judgment that “stenosis severity does not equal clinical consequence” is supported not only by statistical evidence but also by a mechanistic explanation at the level of fluid mechanics. Patient-specific CFD analysis has shown that the hemodynamic consequences of IJVS are segmentally heterogeneous: local high wall shear stress and high-velocity jets occur at the stenosis, whereas vortices occur downstream; the transstenotic pressure gradient increases with stenosis severity, but the pattern of hemodynamic consequences depends on the segment in which the stenosis is located and on the source of compression, rather than on the stenosis percentage alone (8). This suggests that “stenosis percentage” is itself too crude and cannot substitute for assessment of compensation status and the local mechanical environment; this judgment provides fluid-mechanical support for the present hypothesis’s placement of “adequacy of compensation” above “stenosis itself.”

2. Hypothesis Statement

Core proposition: Sclerotic fibrosis of the investing fascia, through loss of elastic buffering and transmission of abnormal mechanical stress to the carotid sheath, reduces collateral compensatory capacity during IJV outflow obstruction and may coexist with insufficient valvular antireflux function; this state of inadequate compensation—centered on collateral compensation, with valvular function as a parallel dimension—is the key mediating variable between fluctuating elevation of intracranial venous pressure and associated clinical symptoms.

Subproposition A (upstream driver): Fibrotic remodeling of the investing fascia driven by chronic forward head posture, aging, and low-grade inflammation is a measurable source of abnormal mechanical stress loading in the carotid sheath region.

Subproposition B (mediating mechanism): The clinical significance of external constraint lies not in whether it produces imaging-defined “stenosis,” but in whether it depletes collateral compensation and valvular function during postural transitions and the Valsalva maneuver.

Subproposition C (effect modification and associated clinical phenotypes): Collateral compensatory capacity is the core effect modifier, and valvular function is a parallel effect dimension. In individuals with adequate compensation or intact valves, the same fascial pathology may manifest only as subclinical changes; in contrast, in those with inadequate compensation or valvular insufficiency, it may manifest as different symptom combinations—including headache, pulsatile tinnitus, cerebral tinnitus, insomnia, autonomic symptoms, vertigo, facial pain, or cognitive complaints—across different individuals. The observation by Hui et al. that “the source of symptom heterogeneity in patients with venous congestion remains unknown” is precisely a direct clinical manifestation of effect modification—it suggests that individual differences in compensation are not random noise but systematic variables that can be jointly explained by upstream mechanical status and connective tissue quality (2). Investing fascial fibrosis itself does not determine the disease phenotype; it depletes collateral compensation, and the manner in which inadequate compensation is expressed under different backgrounds constitutes the mechanical basis of the associated diseases and clinical phenotypes. This paper does not claim that investing fascial fibrosis is the sole or necessary upstream cause of valvular insufficiency; valvular function can be independently influenced by central venous pressure, age, and iatrogenic factors, and is therefore declared in this framework primarily as a parallel effect dimension; its modifying effect is not examined within the core discriminatory test of Prediction 2 but is explored as a second effect dimension within the same analytic framework. In the core mediation test, “inadequate compensation” as used in this paper refers specifically to insufficient collateral compensation; when the clinical phenotype spectrum is concerned, it refers to the combined state of collateral compensation and valvular function. Valvular function is not included in the core discriminatory test of Prediction 2 and is examined only as an exploratory analysis of a parallel effect dimension.

3. Definition of Core Concepts

3.1. Terminological Convention

In this paper, “inadequate compensation” is a composite state variable denoting insufficient collateral compensatory capacity and/or insufficient valvular antireflux function, such that the margin for maintaining outflow is inadequate to buffer fluctuations in intracranial venous pressure when IJV outflow is obstructed. Within this construct, collateral compensatory capacity is the mediator/effect modifier in the core test of Prediction 2; valvular function serves as a parallel effect dimension and is examined exploratorily outside the core test. When the core mediation proposition is concerned, “inadequate compensation” refers specifically to insufficient collateral compensation; when the clinical phenotype spectrum is concerned, it refers to the combined state of collateral compensation and valvular function. This paper does not use “outflow reserve” as an independent term.

3.2. The Investing Fascia and the Carotid Sheath: Anatomical Overlap and Operationalization

The investing fascia is the most superficial layer of the deep cervical fascia; it encloses the sternocleidomastoid muscle, trapezius muscle, parotid gland, and other structures and contributes to the anterolateral wall of the carotid sheath. Posteriorly in the neck, the investing fascia splits to enclose the trapezius muscle, forming the trapezius fascia, and continues in the nape as the nuchal fascia; the two represent the same fascial layer at different segments of the posterior neck and are systematically consistent in embryonic origin, collagen fiber arrangement, and mechanical response patterns. The dense fibrous connections between the investing fascia and the prevertebral fascia provide a trans-level pathway for the transmission of abnormal tension to deeper structures. In the literature describing compression at the intrasheath segment of the carotid sheath, the source of compression is often designated as the sternocleidomastoid muscle or the common carotid artery rather than explicitly named as the “investing fascia”; the investing fascia, as the layer that encloses the sternocleidomastoid muscle and contributes to the anterolateral wall of the carotid sheath, is anatomically highly overlapping with sternocleidomastoid compression, but the “investing fascia” as an independent upstream mechanical variable has not been separately specified within that literature framework—this is precisely the distinction that the present hypothesis seeks to introduce.

This anatomical overlap is not merely of naming significance; it directly determines the testability of the present hypothesis. To partially separate the investing fascia from the sternocleidomastoid muscle at the levels of measurement and intervention, the following operationalization strategies are proposed. (1) At the ultrasound measurement level, using the sternocleidomastoid muscle as an anatomical landmark, the fascial layer at its superficial aspect (i.e., where the investing fascia covers the sternocleidomastoid muscle) and the fascial layer at the deep aspect of the muscle belly and the anterolateral wall of the carotid sheath are measured separately. The sternocleidomastoid muscle belly is used as an internal reference to calculate a “fascia/muscle stiffness ratio.” This ratio can partially correct for the influence of the target muscle’s contraction state on absolute stiffness values, thereby partially converting “muscle contraction” from an uncontrollable confounder into a measurable internal reference, but it cannot fully separate the mechanical contributions of the investing fascia and the sternocleidomastoid muscle. The residual anatomical overlap remains a methodological limitation to be validated rather than a premise that has been resolved. (2) At the surgical release level, the operative target corresponding to the investing fascia is defined as the fascial layer between the sternocleidomastoid muscle and the internal jugular vein (i.e., the layer contributing to the anterolateral wall of the carotid sheath), rather than the sternocleidomastoid muscle fascia itself; intraoperatively, neuromonitoring and venography may be used to confirm that the release plane lies deep to the muscle belly and superficial to the anterolateral sheath wall. The above strategies remain operationalization proposals that have not been prospectively validated. Their value lies in advancing “the investing fascia as an independent variable” from an anatomical claim to an executable, falsifiable measurement protocol, rather than in claiming that the problem of anatomical overlap has been resolved.

3.3. ROI Validity Preconditions

Declaring a measurement protocol, however, does not by itself resolve the logical status of the protocol in the falsification pathway. This paper therefore specifies that the validity of the ROI protocol is not a premise to be presumed but a precondition to be independently evaluated before Prediction 1 can bear falsifying weight. Two preset criteria are proposed: (a) inter-rater agreement in ROI localization reaches an ICC ≥ 0.75 (a threshold to be calibrated in a pilot study, not a validated cutoff); and (b) the ROI-derived fascial stiffness measure shows a prespecified directional concordance with an independent anatomical reference—for example, a higher stiffness value at the anterolateral sheath wall segment than at a control fascial site not continuous with the sheath, or intraoperative confirmation in a surgical substudy that the release plane corresponds to the ROI-localized layer. If the ROI protocol fails these preset validity criteria, Prediction 1 is classified as “measurement not yet ready” rather than “hypothesis falsified.” If the protocol passes these criteria and Prediction 1 remains null, the mediation proposition is substantially weakened without exemption. This three-tier structure comprises a measurement validity precondition, measurement feasibility, and paired validation. It replaces the earlier two-tier distinction between “measurement-level gap” and “paired-validation-level gap.” It closes the logical loop by making the validity of the measuring instrument itself an explicitly evaluable gate rather than an unexamined premise.

3.4. Histological Variation of the Perisheath Fascial Layers

The carotid sheath is not a rigid, closed tube; its compliance is modulated by the mechanical state of the surrounding fascial layers. Within the sheath, the internal jugular vein lies lateral to the artery, and the vagus nerve lies posteriorly between the two; the fascial envelope around the internal jugular vein is relatively loose, making it a structure within the sheath that is susceptible to the external mechanical environment. The relationship between the carotid sheath and the surrounding fascial layers is subject to histological variation and controversy: Hayashi et al., based on a histological study of semiserial sections, pointed out that the “common sheath” of the carotid sheath does not simply fuse with the superficial cervical fascia or the pretracheal layer, but often forms a thick plate with the visceral fascia; the carotid sheath itself is a definite histological structure, but its thickness varies significantly among individuals and among sites (4). This variation is not merely of anatomical descriptive significance: the thickness and degree of fusion of the perisheath fascial layers may constitute effect-modifying variables—in individuals with thicker fascial layers or denser fusion, the same elevation in investing fascial stiffness may produce stronger intrasheath stress transmission. In the exploratory analysis of Prediction 2, imaging proxy indicators of perisheath fascial layer thickness or degree of fusion are included as candidate modifying variables. Modern anatomical studies have further provided a more refined localization for this mechanical pathway: the anterior wall of the carotid sheath is formed by the fusion of multiple fascial layers and can be traced to attachments at the styloid process, the anterior margin of the jugular foramen, and the anterior margin of the carotid canal (9). This finding refines the “mechanical pathway capable of transmitting stress between the extrasheath fascia and the carotid sheath” from a general assertion to the composite fascial layer of the anterior carotid sheath wall and its bony attachment sites at the skull base, suggesting that the mechanical continuity on which the present hypothesis relies can be established independently of nomenclature attribution.

3.5. Operational Indicators, Indicator Hierarchy, and Load Exposure

This paper does not use “outflow reserve” as an independent term. The ability of the internal jugular vein to maintain outflow under external constraint is jointly determined by two variables defined in the existing literature: (1) collateral compensatory capacity, expressed as the degree of vertebral vein dilation (1); and (2) valvular antireflux function, expressed as whether retrograde flow occurs during the Valsalva maneuver (10). Together, these two variables determine whether the same upstream mechanical abnormality translates into symptoms in different individuals, and which category of symptoms it translates into.

At the operational level, the core compensation indicators are the Valsalva-to-resting internal jugular vein diameter ratio (hereinafter referred to as the Valsalva diameter ratio) and the cross-sectional area of the nonjugular drainage system. These two indicators capture whether the venous system can recruit compensatory reserve under load (Valsalva diameter ratio) and whether the anatomical substrate for collateral compensation is sufficient (nonjugular drainage system area); neither is definitionally equivalent to “external constraint.” J2 inspiratory collapse is retained as a downstream marker of external constraint rather than as a core compensation indicator: it directly reflects the presence of a persistent external constraint at that segment, and its association with investing fascial stiffness is therefore a test of the upstream→downstream marker link, not a test of the upstream→compensation mediation link. This conceptual separation is necessary because using J2 inspiratory collapse as the primary compensation indicator would risk circularity—the indicator is itself a downstream expression of the very upstream constraint whose effect on compensation is being tested.

Yin et al. operationalized impaired internal jugular venous drainage as either of the following conditions: time-averaged mean velocity (TAMV) < 4 cm/s on either side at the J2 or J3 segment, or luminal collapse on either side at the J2 segment during inspiration. The TAMV criterion of this composite definition is not incorporated into the indicator hierarchy of this paper; only the J2 inspiratory collapse component is adopted, and it is positioned as a downstream marker of external constraint rather than as a core compensation indicator (see the operational-level paragraph above). The second condition—inspiratory luminal collapse at the J2 segment—is particularly close to the mechanistic logic of the present hypothesis. During inspiration, intrathoracic pressure decreases and venous return increases, so the normal internal jugular vein should dilate. If inspiratory collapse occurs at the J2 segment, this suggests that a persistent external constraint exists at that segment, causing the vein to be compressed closed precisely when it needs to dilate. Among the 106 patients with subjective memory complaints in that study, the prevalence of impaired internal jugular venous drainage was significantly higher in the cognitively impaired group (68% vs. 30%, p < 0.001), and the IJV drainage–impaired group had significantly lower MMSE scores (median 27 vs. 29, p = 0.013) and MoCA scores (median 23 vs. 26, p < 0.001). The authors specifically noted that after incorporating “luminal collapse during deep inspiration” into the definition, the detection rate of impaired IJV drainage in the cognitively impaired group increased further (11).

“Load exposure” is not a methodological inference unique to the present hypothesis, but rather a clinical phenomenon that has already been independently named. In a peer-reviewed study of women occupationally exposed to prolonged upright posture, De Sio et al. defined “White Compression”—a venous compression syndrome characterized by complete obstruction of IJV flow, with etiologies including postural, muscular, fascial, anatomical, or bony abnormalities. Its key features closely parallel the “inspiratory collapse” described by Yin et al.: this complete compression is not visible on conventional color Doppler in the supine position and can be detected only during head rotation or the Valsalva maneuver; among the women workers in that study, the detection rate of White Compression was significantly higher in the standing-work group, whereas it was zero in both the sedentary and mixed groups (12). White Compression confirms the same logic from the perspective of occupational medicine: fascial compression of the IJV may manifest only under specific postures or loads, and resting imaging will miss the diagnosis. It elevates “the necessity of dynamic assessment” from a methodological suggestion of the present hypothesis to a clinical entity that has already been independently named and has peer-reviewed prevalence data.

The ubiquity of IJV stenosis under dynamic load has been quantified in the largest dynamic venographic pressure series to date: Ashraf et al. evaluated each IJV in 223 patients with suspected cerebral venous outflow obstruction in four head positions—neutral, 90° right rotation, 90° left rotation, and neck flexion—and found that 94% of patients developed at least moderate stenosis with head rotation, 84% developed severe or occlusive stenosis, and neck flexion caused severe or occlusive stenosis in 74% of the IJVs studied; 43.5% of patients had a rotational gradient ≥6 mmHg, and 17.5% had a gradient ≥10 mmHg; contralateral rotation stenosis was located predominantly at the C1 level, whereas ipsilateral rotation stenosis was located predominantly at the C2–4 level (13). This study, with the largest sample to date, confirmed the ubiquity and pressure consequences of “normal at rest, exposed under load” and advanced the postural dependence of compression segments to a quantifiable imaging pattern.

The study by Pardo et al. supplemented the anatomical basis of compensation from the structural side: total venous cross-sectional area was significantly smaller in the cognitively impaired group than in cognitively healthy controls (139.77 mm² vs. 166.55 mm², p = 0.004), with a particularly significant difference in the nonjugular venous system (including the vertebral venous plexus and pterygopalatine plexus) (41.21 mm² vs. 54.5 mm², p = 0.045) (14). This implies that compensatory capacity is not only functional (Valsalva reactivity or inspiratory dilation capacity) but also has a measurable anatomical basis.

4. Anatomical and Mechanical Basis

The investing fascia, the carotid sheath, and the internal jugular vein constitute a hierarchically mechanically coupled system. The investing fascia is the outermost mechanical interface, and its passive tension state determines the level of stress transmitted to deeper structures; the carotid sheath is the intermediate layer; and the internal jugular vein is the terminal structure within the sheath that is susceptible to external influence. This system exhibits asymmetric sensitivity: the internal jugular vein wall is thin and its intraluminal pressure is low, making it highly sensitive to increases in extrasheath pressure, whereas the artery is relatively tolerant because of its thicker wall and higher intraluminal pressure. Therefore, the increased passive tension produced by investing fascial fibrosis preferentially acts on the vein rather than the artery within the sheath. From a mechanical magnitude perspective, existing methodological studies suggest that the pressure required to reach the deep cervical fascia is on the order of 6 N/cm²—a magnitude indicating that external constraint within a physiologically attainable load range is sufficient to be transmitted to the perisheath fascial layers, thereby making the “investing fascia→intrasheath vein” mechanical pathway feasible in magnitude; however, this magnitude derives from methodological literature and remains to be validated in paired measurements with SWE at the investing fascia–specific segment within the framework of the present hypothesis.

The constraint exerted by cervical muscles on the IJV is not a theoretical inference but has already been directly observed physiologically. In a 1988 ultrasound study of 10 healthy volunteers, Patra et al. observed that under two dynamic loads—mouth opening and deep inspiration—the IJV area above the omohyoid muscle increased statistically significantly; the authors accordingly confirmed that contraction of this muscle compresses the IJV along its cervical course, thereby altering cerebral venous hemodynamics (15). This finding provides the most direct physiological evidence that “cervical muscle/fascial structures can compress the IJV from the outside,” and its “manifest under dynamic load” feature is highly consistent with the logic of White Compression and J2 inspiratory collapse. It suggests that extrasheath constraint is not limited to static fascial fibrosis but also includes dynamic muscle contraction—the latter may be one of the shared physiological mechanisms underlying White Compression and J2 inspiratory collapse. Cha et al. further advanced this muscular constraint from a physiological phenomenon to a recognizable clinical entity: in a case series of 12 patients with vertigo and headache caused by compression of the IJV by the sternocleidomastoid/omohyoid complex, symptoms were provoked by ipsilateral head rotation and flexion, were often bilateral, and venography confirmed restoration of flow after relief of compression; symptom relief was achievable by surgery or neurotoxin (16). This provides case-series–level evidence, stronger than isolated case reports, for “muscular constraint as a soft-tissue constraint subtype independent of bony compression.”

The attachment of the upper end of the carotid sheath to the styloid process and the fibrocartilaginous tissue around the jugular foramen constitutes a bony anchor for stress transmission to the skull base. Modern anatomical studies have confirmed that the anterior wall fascia of the carotid sheath can be traced to attachments at the styloid process, the anterior margin of the jugular foramen, and the anterior margin of the carotid canal (9), providing a more precise anatomical localization for this bony anchor. When investing fascial tension is abnormally elevated, this anchor region may become a site of stress concentration and may exert additive effects with bony compression at the styloid process–C1 transverse process, providing a mechanical entry point for understanding the interaction between bony and soft-tissue constraints in Eagle jugular syndrome (17–18). Developmental histological studies have further provided a more refined histological substrate for the “mechanical pathway capable of transmitting stress between the extrasheath fascia and the carotid sheath”: in a rabbit model, a three-layered architecture consisting of an inner fascial layer, an intermediate zone, and an outer fascial layer was consistently present around the artery, vein, and vagus nerve within the carotid sheath; the inner fascial layer of the artery developed earliest and thickened most markedly, whereas the outer fascial layers of adjacent structures exhibited fusion potential, which the authors interpreted as a structural trace possibly left by “external mechanical interactions from surrounding tissues” (19). This finding links “mechanical continuity” no longer merely to a general assertion of fascial network continuity but to an observable structural feature—“outer fascial layer fusion.” This evidence, however, derives from a rabbit model and developmental stages; when extrapolating it to pathological mechanical loading in human adults with investing fascial fibrosis, species differences and differences in developmental–pathological time scales are declared as prior limitations.

5. Mechanistic Chain

5.1. Upstream Factors

Chronic forward head posture, aging-related connective tissue remodeling, and chronic low-grade inflammation can drive fibrotic remodeling of the investing fascia, manifested as increased collagen deposition and a decreased proportion of elastic fibers. This hypothesis does not attempt to elaborate its molecular signaling pathways in this paper; its testable starting point is the mechanical phenotype rather than the molecular phenotype: whether in vivo SWE can detect changes in investing fascial stiffness, and whether such changes are associated with IJV compensatory indicators. Liao et al. directly measured in healthy adults using shear-wave elastography that the shear modulus of the nuchal fascia was significantly higher in the forward head posture than in the neutral position (20). This provides in vivo SWE evidence for “postural load→cervical fascial stiffness change” and constitutes the first link in the upstream chain of the present hypothesis. This upstream susceptibility is not uniformly distributed across all individuals: Midtlien et al. described a subgroup of IJV outflow obstruction in the context of connective tissue disorders, in which Ehlers-Danlos syndrome accounted for 55% and the cross-sectional areas of the IJV and vagus nerve were reduced, suggesting that systemic connective tissue fragility may constitute a susceptibility background for fibrotic remodeling of the investing fascia and depletion of compensatory capacity (21). This study was a single-center retrospective analysis without healthy controls and did not measure investing fascial stiffness or IJV compensatory indicators; therefore, it cannot directly test the mediating chain of the present hypothesis. Its value lies in converting “connective tissue quality” from an implicit histological variable into a concept with a defined clinical phenotype and an identifiable patient subgroup, thereby providing a citable upstream susceptibility entry point for Subproposition A. This connective tissue susceptibility has gained more specific imaging support in terms of anatomical localization: Hauser et al. reported in 84 patients with hypermobile Ehlers-Danlos syndrome (hEDS) that the IJV cross-sectional area at the C1 level was significantly smaller than at the C4–C5 level, which the authors interpreted as evidence of carotid sheath compression at the C1 level; this cohort also commonly exhibited forward head posture, reduced cervical lordosis, and ligamentous cervical instability (22). This study was a single-center retrospective observation without direct between-group comparison with healthy controls and did not measure investing fascial SWE stiffness or IJV compensatory indicators; therefore, it cannot directly test the mediating chain of the present hypothesis. Its value lies in advancing “connective tissue quality” as an upstream susceptibility from the macro-level coexisting phenotype in (21) to an imaging localization at the specific anatomical hub of the carotid sheath, thereby providing a citable population-level evidence pointing to perisheath mechanical constraint for Subproposition A. The theoretical narrative linking “postural load→IJV compression” is not limited to fascial mechanisms. Hauser et al. proposed that a forward head–face-down lifestyle leads to “creep” of the posterior cervical ligamentous complex, which in turn causes ligamentous cervical instability and anterior displacement of C1, encroaching on the IJV and vagus nerve within the carotid sheath and ultimately leading to intracranial hypertension and impaired cerebral fluid outflow; their retrospective chart review of 227 cases reported measurements of cervical structure, IJV, and optic nerve sheath, and included a case example in which the IJV “opened” and symptoms improved after cervical structural treatment (23). The causal mediator in that paper is ligamentous laxity and bony displacement, rather than investing fascial fibrosis; its data derive from retrospective charts at a private institution and uncontrolled case observations, and the paper type is Hypothesis and Theory. The value of that paper lies in providing a parallel structural-mechanical explanation for the broad pathway “postural load→IJV compression→symptoms,” and it likewise advocates dynamic assessment over resting imaging—but it does not constitute direct support for the core chain “investing fascia→inadequate compensation.”

5.2. Stress Transmission

The elevated passive tension of the fibrotic investing fascia is transmitted to the carotid sheath through the collagen network of the deep cervical fascia. The multilayered fascial structure of the anterior carotid sheath wall and its skull base attachments provide a localizable anatomical pathway for this transmission (9); the fusion potential of the outer fascial layers of adjacent structures observed in developmental histology provides a histological reference for “external mechanical action leaving structural traces in the sheath fascial architecture” (19). The histological variation in the relationship between the carotid sheath and surrounding fascial layers suggests that this transmission should be understood as mechanical continuity, rather than as anatomical equivalence in the sense that “the investing fascia directly constitutes the carotid sheath” (4).

5.3. Mediating Variables

Persistent loading of extrasheath stress increases the external constraint on the internal jugular vein. Its consequence is not immediate luminal occlusion, but rather a progressive decline in collateral compensatory capacity and valvular function—which may not be apparent at rest, and only when postural transitions, inspiration, or the Valsalva maneuver require the recruitment of compensatory reserve does inadequate compensation become exposed as hemodynamic decompensation. The J2 inspiratory collapse defined by Yin et al. is precisely the direct imaging expression of this “normal at rest, exposed under load” feature (11); within the indicator hierarchy of this paper, it serves as a downstream marker of external constraint rather than as a core compensation indicator, and its role in Prediction 1 is correspondingly confined to the upstream→marker link. The White Compression named by De Sio et al. provides an independent clinical entity of the same phenomenon from the perspective of occupational medicine (12); Ashraf et al. further quantified, in a 223-case dynamic venographic pressure series, the ubiquity of severe IJV stenosis and transstenotic pressure gradients under rotational and flexion loads (13). The ultrasound observations of the omohyoid muscle by Patra et al. provide a specific physiological example of muscular constraint (15); the case series by Cha et al. established vertigo and headache caused by compression of the IJV by the sternocleidomastoid/omohyoid complex as a recognizable, intervenable clinical entity (16). The acute effect of head and neck mechanical loading on IJV flow velocity has been directly observed in humans: the study by Ersoy Karka et al. showed that cervical hyperextension can cause a decrease in IJV flow velocity and acute cerebral congestion, while an increase in optic nerve sheath diameter suggests elevated intracranial pressure (24). This finding directly links “posture/load” to “impaired IJV outflow” in humans without requiring chronic fibrosis as an intermediary—it demonstrates that the head-neck mechanical state itself is sufficient to acutely alter IJV outflow in humans, thereby lending greater biological plausibility to the hypothesis that “the investing fascia serves as a chronic source of mechanical constraint.” Dynamic head-and-neck rotational CT venography further shows that IJV compression has a marked postural and segmental dependence, and that musculovascular compression predominates among dual-structure compressions (25). This implies that extrasheath constraint is not limited to static fascial fibrosis but also includes dynamic muscle contraction and postural load.

5.4. Downstream Expression

Inadequate compensation is insufficient to buffer the fluctuating elevation of intracranial venous pressure. Pressure is transmitted through the venous sinuses to the dura mater, stretching the sinus wall and activating the trigeminovascular system to produce headache; pressure waves may also act on structures related to the auditory pathway to produce pulsatile tinnitus or cerebral tinnitus. This mechanical transmission does not remain at the level of venous pressure alone but can also be transmitted to the mechanical state of the brain parenchyma: Hatt et al. directly demonstrated using MR elastography that when jugular vein compression alters cranial venous drainage, the shear modulus (stiffness) of brain tissue increases accordingly, and the magnitude of the increase depends on the proportion of blood drained through the internal jugular vein during compression—individuals who maintained IJV drainage exhibited higher brain stiffness than those who shunted blood to alternative pathways (26). This provides direct human experimental evidence for “extrasheath constraint→altered venous drainage→altered brain parenchymal mechanics.” This study, however, used acute, exogenous jugular vein compression; when extrapolating to the chronic, endogenous constraint caused by investing fascial fibrosis, differences in time scale and in the mode of mechanical loading are limited in interpretation. In the population with venous pulsatile tinnitus, Hsieh et al. measured cerebrospinal fluid pressure by lumbar puncture in 27 patients with venous pulsatile tinnitus and sigmoid sinus wall abnormalities and found a mean intracranial pressure of 212.5 ± 47.3 mmH₂O, and the ΔICP under the internal jugular vein compression test was linearly correlated with the morphological difference between the bilateral transverse–sigmoid sinuses (27); this study was a retrospective case series without healthy controls, and its value lies in providing a phenotype-specific measured anchor for “venous outflow obstruction→elevated intracranial pressure,” rather than in providing direct evidence for the investing fascial chain. On this basis, persistent disturbance of the venous pressure gradient also connects mechanical abnormalities to longer-term downstream consequences through the interface of the glymphatic system. The review by Eliav et al. explicitly stated that cerebral venous outflow obstruction disrupts the stable venous pressure gradient on which the glymphatic system depends, reducing the clearance efficiency of β-amyloid, and that accumulation of β-amyloid further damages venous and perivascular structures, forming a vicious cycle of “venous insufficiency→impaired glymphatic clearance→toxic protein accumulation→further venous damage” (28). This implies that the downstream expression of inadequate compensation can be not only acute (headache, tinnitus) but also chronic and cumulative.

The severity of the consequences of inadequate compensation can reach an extreme under specific loading conditions. Jiang et al. reported a patient with bilateral elongated styloid processes who underwent surgery in a neck-rotation position and postoperatively developed irreversible intracranial hypertension and died due to severe obstruction of bilateral IJV outflow tracts; their multi-position rotational CTV analysis further showed that among 240 vascular states in 42 patients with ESP, severe IJV stenosis or occlusion accounted for 33.3%, with muscle–muscle (33.75%) and muscle–vessel (28.75%) compression predominating, whereas bone–bone compression accounted for only 13.75% (25). This data set, derived from a population defined by bony abnormalities, on the one hand provides reverse support for the predominance of soft-tissue constraint under dynamic load, and on the other hand provides an extreme clinical anchor for the variable structure in which “adequacy of compensation is closer to the severity of consequences”; however, the perioperative setting of this case and the specificity of the ESP population determine that it cannot be directly extrapolated to the daily compensatory state of chronic investing fascial fibrosis.

5.5. Effect Modification

In individuals with adequate collateral compensation, even if the internal jugular vein is subjected to external constraint, dilation of the vertebral venous network can still maintain overall cerebral venous outflow, and adequate compensation can offset the effect of this chain; in contrast, in individuals with valvular insufficiency, retrograde transmission of intrathoracic pressure to the intracranial compartment during the Valsalva maneuver coexists in parallel with inadequate collateral compensation, jointly reducing the outflow margin; whether the two are additive or interactive is not presupposed by this hypothesis and is left to the exploratory analysis of Prediction 2. Valvular insufficiency can exist independently of investing fascial constraint; this paper therefore examines it as a parallel effect dimension rather than as a necessary mediator of the investing fascial chain. The study by Doepp et al. showed that the proportion of IJV valvular insufficiency in patients with exertional headache was significantly higher than in controls, and retrograde flow always occurred on the dominant drainage side (10). The prospective data of Adachi et al. provide longitudinal support for the clinical consequences of the valvular dimension: among 302 patients who underwent jugular vein duplex ultrasonography, spontaneous jugular venous reflux was significantly associated with lower MMSE and MoCA-J scores, with executive function and memory impairment particularly prominent, and individuals with severe reflux had a significantly higher proportion of incident dementia during follow-up (29). Roh et al. reported in 57 elderly men undergoing robot-assisted laparoscopic radical prostatectomy that IJV valvular insufficiency was present in 38% in the supine position without pneumoperitoneum and rose to 54% under the Trendelenburg position combined with pneumoperitoneum; patients with valvular insufficiency showed a statistically significant decline in postoperative MMSE scores, whereas most other neurocognitive tests did not reach significance (30). The load in that study was acute and iatrogenic pressure elevation, and the cognitive consequence was observed only on the MMSE; its value lies in demonstrating, with prospective human data, a phenomenon that is structurally isomorphic to the logic of the hypothesis—“valvular defects are partially unmasked at rest, further exposed under load, and associated with cognitive consequences.” The clinical association of valvular insufficiency also exhibits phenotype selectivity: Domitrz et al. found no significant difference in the prevalence of IJV valvular insufficiency or in reflux duration between migraine patients and controls (31), suggesting that the valvular dimension is not a universal cause across headache phenotypes but is more likely a parallel effect dimension modified by phenotype and loading conditions.

6. Evidence Base: Link-by-Link Assessment of the Chain

6.1. Evidence Grading Statement

This section grades and assesses each link of the chain according to the categories of “direct human paired evidence—indirect human evidence—intervention-side evidence—methodological reference—extrapolative evidence.” For evidence that is indirect, extrapolative, or methodological in nature, the following text indicates that it cannot directly fill the core gap. The evidence structure comprises three tiers rather than two. The measurement-validity tier—whether the ROI protocol meets prespecified validity criteria—is a precondition to be evaluated before Prediction 1 can bear falsifying weight; if the protocol fails these criteria, Prediction 1 is classified as “measurement not yet ready” rather than “hypothesis falsified.” The measurement-feasibility tier—whether SWE can be executed at the anterolateral segment of the investing fascia with existing equipment—is already methodologically feasible. The paired-validation tier—whether investing fascial stiffness is associated with IJV compensatory indicators in a paired analysis—is the true core to be filled. The measurement-validity tier is not a restatement of the measurement-feasibility tier: feasibility asks whether the measurement can be performed, whereas validity asks whether what is measured corresponds to the intended construct. Two core gaps remain: first, no human study has yet paired SWE stiffness of the anterolateral segment of the investing fascia with IJV flow parameters; second, no controlled trial has yet used this pairing as an endpoint. Limitations are summarized uniformly in the paragraphs below rather than repeated at the end of each paragraph. The design implications of this three-tier structure are specified in Section 6.4.

6.2. Evidence Grading by Chain Link

For the upstream link of posture-related fascial stiffness, Liao et al. (20) provide human SWE evidence directly supporting the association between forward head posture and increased nuchal fascial stiffness; the key limitation is that the measurement site was the nuchal fascia, not the anterolateral segment of the investing fascia. For the upstream link of fibrotic stiffness magnitude, Dapper et al. (32) provide a human SWE magnitude reference, but the fibrosis was radiation-induced and the measurement covered the cervical fascia as a whole. For methodological reliability of fascial SWE, Zandi et al. (33) reported test–retest reliability, but the site was the posterior cervical fascia rather than the investing fascia. For transmission and perisheath fascial continuity, Schachtel et al. (9) provide human anatomical evidence and Zhao et al. (19) provide rabbit developmental histology; the latter carries species and developmental–pathological time-scale extrapolation limitations. For mediation by collateral compensation, Han et al. (1), Pardo et al. (14), and Yin et al. (11) provide human clinical, imaging, and functional evidence that is relatively direct, but the evidence is predominantly cross-sectional and the investing fascia was not measured. For mediation by load exposure, De Sio et al. (12), Ashraf et al. (13), and Jiang et al. (25) provide human dynamic imaging and occupational medicine evidence, but these studies were not paired with investing fascial SWE. For mediation by muscular constraint, Patra et al. (15), Cha et al. (16), and Ersoy Karka et al. (24) provide human physiology, case-series, and acute-loading evidence, but the samples were small and fascial stiffness was not measured. For the downstream link of brain parenchymal mechanics, Hatt et al. (26) provide human MR elastography evidence, but the compression was acute and exogenous rather than chronic and endogenous. For the intervention side of perisheath release, Abeysinghe et al. (34), Lu et al. (35), Suri et al. (36), and Aghayev et al. (37) provide human surgical cohort or controlled evidence, but no SWE confirmation was obtained that the investing fascia itself was released. For the intervention side of muscular release, Simka et al. (6), Gianesini et al. (7), and Cha et al. (16) provide case reports or case series, but the samples were small and fascial stiffness was not measured. For the intervention side of manual therapy or RCTs, Uzun et al. (38), Raja et al. (39), and Mandolesi et al. (40) provide RCT or before–after comparison evidence, but outcomes were not paired with IJV parameters and the investing fascia was not measured. For the parallel dimension of valves, Doepp et al. (10), Adachi et al. (29), Roh et al. (30), and Domitrz et al. (31) provide human clinical, prospective, or negative findings, but the evidence shows phenotypic selectivity and does not constitute a core mediation test.

6.3. Upstream Link: Posture-Related Fascial Stiffness

Investing fascial fibrosis has a measurable mechanical phenotype basis, and the acute effect of postural load on cervical fascial stiffness has obtained direct human SWE evidence. Liao et al. directly measured in healthy adults using shear-wave elastography that the shear modulus of the nuchal fascia was significantly higher in the forward head posture than in the neutral position; the intra-rater reliability of nuchal fascial SWE was ICC 0.63–0.89, and the inter-rater reliability was 0.54–0.82 (20). This is currently the most direct human data addressing Subproposition A—the first link of the causal chain “forward head posture→increased cervical fascial stiffness” has, for the first time, been captured by SWE in vivo. At the same time, its methodological implications must be noted: this reliability is lower than reported values for cervical fascial SWE under resting conditions, suggesting that measuring fascial stiffness in vivo under dynamic postural conditions is more challenging than under resting conditions—this itself is a measurement condition control that must be incorporated into the design of Prediction 1. Zandi et al. further demonstrated that SWE measurements of cervical fascial stiffness and thickness had good to excellent test–retest reliability in healthy individuals and in patients with chronic neck pain (fascial stiffness ICC(3,1) ≥ 0.90; thickness and fascia/subcutaneous fat stiffness ratio ICC ≥ 0.80), but their measurement site was the posterior cervical fascia rather than the anterolateral segment of the investing fascia (33). Therefore, “cervical fascial SWE can be reliably measured” already has a methodological basis, whereas the measurability of “the anterolateral segment of the investing fascia” still requires specific validation. The magnitude of change in cervical fascial stiffness under fibrotic conditions has tissue-specific SWE data available for reference: Dapper et al. reported in patients after head and neck radiotherapy that cervical fascial stiffness increased from 22.7 kPa to 46.4 kPa and muscle stiffness increased from 21.5 kPa to 47.0 kPa, and that SWE could reliably distinguish fibrotic changes among different tissue types (32). The fibrosis in that study was radiation-induced and differs etiologically from the chronic posture/inflammation-driven fibrosis of interest to the hypothesis; its measurement site was the cervical fascia as a whole rather than the anterolateral segment of the investing fascia; and it does not provide paired data with IJV compensatory indicators. The value of this evidence lies in providing a citable stiffness magnitude reference for the construct of “investing fascial fibrosis,” so that the operational definition of “investing fascial SWE stiffness” in Prediction 1 is no longer entirely unsupported, but it does not constitute filling of the core gap. No human study, however, has yet directly used “the degree of investing fascial fibrosis” and “compression of the internal jugular vein within the carotid sheath” as paired endpoints. This is the weakest link of the present hypothesis and is acknowledged candidly.

6.4. Measurement Feasibility and Design Implications of the Three-Tier Structure

Filling the paired-validation gap does not depend entirely on “awaiting future studies.” The ROI localization strategy using the sternocleidomastoid muscle as an anatomical landmark can make SWE measurement of the “anterolateral segment of the investing fascia” feasible with existing equipment; its paired analysis with IJV flow parameters can be completed first in a single-center cross-sectional design, without awaiting longitudinal or interventional data. Regarding the evidence gap declared in Boundary Four of Section 9, the three tiers specified in the evidence-grading statement above carry distinct implications for study design. The measurement-validity tier is a precondition that is evaluated before Prediction 1 can bear falsifying weight. The measurement-feasibility tier is already methodologically feasible with existing equipment. The paired-validation tier—whether investing fascial stiffness is associated with IJV compensatory indicators in a paired analysis—is the true core to be filled. The measurement-validity tier is not a restatement of the measurement-feasibility tier: feasibility asks whether the measurement can be performed, whereas validity asks whether what is measured corresponds to the intended construct. The present hypothesis advances both the feasibility tier (through the ROI localization protocol) and the validity tier (through the prespecified criteria in Section 3), while candidly declaring that the paired-validation tier remains the core gap. This three-tier distinction has direct implications for the design of Prediction 1: the null hypothesis test of Prediction 1 does not depend on new equipment or new technology but on ROI standardization, measurement validity gate evaluation, and measurement condition control—the latter being a methodological agenda that the present hypothesis can advance now.

6.5. Clinical Entity Status of Intrasheath Soft-Tissue Compression

The clinical entity status of intrasheath soft-tissue compression of the internal jugular vein has been jointly confirmed by the naming of White Compression, anatomical reviews, case series, and dynamic imaging studies, but targeted upstream intervention remains insufficient. The anatomical review by Dincă et al. confirmed that the source spectrum of IJV compression extends far beyond the styloid process–C1 transverse process; the digastric muscle, omohyoid muscle, sternocleidomastoid muscle, hyoid bone, and tortuous carotid artery can all constitute compression, making “soft-tissue constraint” a clinical entity independent of bony etiologies (5). Dynamic head-and-neck rotational CT venography further quantified the distribution of compression patterns: muscle–vessel and muscle–muscle compression predominate among dual-structure compressions, whereas bone–bone compression accounts for a lower proportion; moreover, compression exhibits postural and segmental dependence, and ipsilateral perijugular collateral circulation increases significantly during rotation (25). The 223-case dynamic venographic pressure series of Ashraf et al., with the largest sample to date, confirmed the ubiquity of severe IJV stenosis and transstenotic pressure gradients under head rotation and neck flexion loads, and revealed a segmental pattern in which contralateral rotation stenosis is located predominantly at the C1 level and ipsilateral rotation stenosis predominantly at the C2–4 level (13). This imaging evidence directly advances “soft tissue (muscle/vessel) as an IJV constraint source independent of bony compression” from an anatomical inference to a quantifiable dynamic imaging pattern. De Sio et al. named “White Compression” from the perspective of occupational medicine—a complete IJV compression whose etiologies include fascial abnormalities and which is invisible on resting Doppler—and their peer-reviewed data confirmed the significant enrichment of this phenomenon among standing workers (12). The case series by Cha et al. confirmed from the clinical intervention side that vertigo and headache caused by compression of the IJV by the sternocleidomastoid/omohyoid complex can achieve symptom relief through surgery or neurotoxin (16). This provides multiple clinical–anatomical interfaces for the upstream localization of the present hypothesis. Existing studies also point out, however, that no validated and widely adopted venous decompression technique is available for compression caused by soft tissue or arteries, and that omohyoid resection in isolated case reports remains experimental; moreover, such cases show minimal symptom improvement at 3 months under conservative treatment. The 2025 systematic review further confirmed this evidence status: after searching the surgical intervention literature, Petersingham et al. included only 14 studies, ranging from case reports to small single-center cohorts; styloidectomy was the most common procedure (124 cases), and most patients reported symptom relief, but complications such as neurological deficits, facial palsy, and symptom recurrence occurred in 13 cases; the authors explicitly stated that large cohorts or clinical trials are lacking to analyze surgical intervention for cervical IJV compression (41). This state of “entity identified, intervention still inadequate” is precisely the position that the present hypothesis seeks to fill—but it also means that the investing fascial constraint proposed by the present hypothesis can currently be advanced only as a candidate mechanism of soft-tissue compression, rather than as confirmed by that literature framework.

6.6. Mechanical Constraint Spectrum and Reversibility

The extrasheath mechanical environment can alter IJV geometry, and the effect is reversible. Stone et al. reported in 42 healthy volunteers that after wearing a rigid cervical collar, the IJV cross-sectional area increased significantly, with a mean increase of 37% (95% CI 20%–53%) (42); Kroeker et al. further showed that after 4 hours of cervical collar wear, the IJV cross-sectional area doubled from baseline and returned to near baseline within 5 minutes after removal (43). This demonstrates that the response of the internal jugular vein to extrasheath constraint is acute, measurable, and reversible. The ultrasound observations of the omohyoid muscle by Patra et al. supplement the same logic from the perspective of physiological muscle contraction: contraction of this muscle during mouth opening and deep inspiration can alter IJV area (15). Ersoy Karka et al. further directly linked head-neck mechanical loading to IJV flow velocity: cervical hyperextension can reduce IJV flow velocity and cause acute cerebral congestion, while an increase in ONSD suggests elevated intracranial pressure (24). The clinical reversibility of muscular constraint also has direct evidence: Simka et al. reported a patient with multiple sclerosis in whom the mid-portion of the IJV was compressed by an anomalous omohyoid muscle, with Doppler showing complete luminal collapse and no outflow; 3 weeks after surgical transection of the muscle, ultrasound confirmed complete venous decompression and full restoration of outflow (6). Gianesini et al. reported another patient with chronic cerebrospinal venous insufficiency in whom omohyoid compression of the IJV was confirmed by MRV and ultrasound; after surgical muscle transection plus patch angioplasty, IJV flow was restored and neurological symptoms improved (7). The case series by Cha et al. advanced this muscular constraint from isolated cases to a recognizable, intervenable clinical entity (16). Together, the above seven sets of evidence constitute a mechanical constraint spectrum: an external device (cervical collar)—physiological muscle contraction (omohyoid)—postural load (cervical hyperextension)—clinical muscular compression and its surgical reversal.

6.7. Collateral Compensation and the Parallel Valvular Dimension

Collateral compensation (and the parallel valvular dimension), rather than stenosis itself, more closely approximates the variable structure underlying clinical outcomes. In the 283-case study, the OR for severe vertebral vein dilation was 0.184 (95% CI 0.092–0.366) (1). Pardo et al. showed at the structural level that total venous cross-sectional area was smaller in cognitively impaired individuals, with particularly marked reductions in the nonjugular venous system (vertebral venous plexus and pterygopalatine plexus) (14). Yin et al. provided an effect size at the functional operational level: among 106 patients with subjective memory complaints, the prevalence of impaired internal jugular venous drainage—defined as TAMV < 4 cm/s or J2 inspiratory collapse—was 68% vs. 30% in the cognitively impaired group (p < 0.001) and was independently associated with lower MMSE and MoCA scores (11). Functional indicators (inspiratory collapse), structural indicators (total venous volume), and effect sizes (OR 0.184; 68% vs. 30%) all point jointly to the same mediating variable: whether collateral compensation and valvular function are adequate. The patient-specific CFD analysis by Li et al. supplemented this judgment from the fluid mechanics side: the hemodynamic consequences of IJVS are segmentally heterogeneous; the high wall shear stress and jets at the stenosis, and the downstream vortex pattern, depend on the stenotic segment and the source of compression rather than on the stenosis percentage alone; J1–J2 soft-tissue/arterial compression and J3 bony compression are not equivalent in terms of intervention feasibility or hemodynamic consequences (8). This provides a mechanistic footnote at the fluid mechanics level for “stenosis severity ≠ consequence.”

Valvular function and intracranial retrograde flow are parallel effect dimensions with longitudinal clinical consequences. The four sets of evidence described above (enrichment in exertional headache by Doepp et al. (10), prospective cognitive association by Adachi et al. (29), acute load exposure by Roh et al. (30), and phenotype-selective negative findings by Domitrz et al. (31)) have been detailed in Section 5 under “Effect modification”; here, only their functional positioning for the present hypothesis is emphasized: valvular defects are partially unmasked at rest and further exposed under load, and their clinical association is modified by phenotype—this is consistent with the declaration of a “parallel effect dimension” rather than a necessary mediator of the investing fascial chain.

After relief of the upstream constraint, the responses of different downstream phenotypes exhibit systematic differences. The study by Bai et al. provided more precise quantitative data: in patients with IJVS, headache and tinnitus improved significantly after stent placement (p < 0.01), whereas improvement in visual loss and papilledema did not reach statistical significance at short-term follow-up; at the same time, intracranial pressure and the mean pressure gradient both decreased significantly. At long-term follow-up, vision and papilledema also improved significantly (44). These data indicate that, even when the venous pressure gradient is significantly corrected, headache and tinnitus still exhibit higher short-term “responsiveness” than papilledema. This pattern of “symptom-dimension–selective response” itself suggests that different downstream pathways do not have the same sensitivity to relief of the same upstream constraint. This pattern has also been independently observed in a targeted surgical cohort: Margraf et al. reported that after surgery targeting jugular venous outflow obstruction, the improvement rates were highest for uncontrollable seizures/shaking episodes, headache, and eye pain (87.5%, 81.3%, and 81.0%, respectively), whereas preoperative brain fog (98.0%), headache (96.0%), and fatigue/low energy (92.0%) were the most frequent complaints (45). That study was a surgical cohort with patient-reported outcomes as symptoms and did not measure investing fascial status; therefore, it cannot directly test the mediating chain of the present hypothesis; however, its pattern—“the magnitude of response of different symptoms to relief of the same upstream constraint is not uniform”—is consistent in direction with the stent data of Bai et al. (44), and together they suggest that the sensitivity of downstream phenotypes to restoration of compensation is hierarchically different—precisely the phenomenon that Prediction 4 must positively explain.

6.8. Intervention-Side Evidence

Perisheath fascial release itself already has surgical precedent and is accompanied by paired improvement in IJV stenosis and symptoms. Abeysinghe et al. reported the quantitative outcomes of 27 patients who underwent combined styloidectomy + internal jugular vein fasciotomy (IJV fasciotomy) + C1 transverse process resection: IJV stenosis grade improved by a mean of 1.89 points (p < 0.0001); all symptom severity scores except dizziness improved significantly, with the greatest improvement in headache (Δ = 1.85, p = 0.0002) (34). More direct controlled evidence comes from Lu et al.: among 47 patients with J3 bony compression, compared with the group receiving partial drilling of the atlas transverse process alone, the group receiving combined release and perfusion technique had an overall symptom improvement rate of 62.5% vs. 20%, an IJV stenosis relief rate of 84.3% vs. 46.67%, and a hemodynamic improvement rate of 75% vs. 40% (all p < 0.05) (35). This set of controlled data directly points to a judgment: adding soft-tissue release beyond bony decompression can yield measurable additional symptom, imaging, and hemodynamic benefits—this is precisely positive intervention-side support for the core claim of the present hypothesis that “soft-tissue constraint exists in addition to bony constraint.” Suri et al. further provided hemodynamic localization data: the maximum flow velocity gradient was most frequently located between the carotid bulb and the sternocleidomastoid muscle (43.64%); although the overall maximum gradient did not change significantly after surgery, the flow velocity gradient at the preoperative maximum gradient point decreased by a median of 36.9 cm/sec (p < 0.001), and quality of life improved comprehensively (36). This indicates that the hemodynamic benefit of surgery is localized and that soft tissue (the sternocleidomastoid muscle) and bony structures (C1) jointly constitute the compression site. Aghayev et al. explicitly listed “carotid sheath opening” as an independent step in the circumferential decompression procedure and reported a significant postoperative increase in IJV cross-sectional area (right, 18.3→46.1 mm², p = 0.0058; left, 10.1→28.8 mm², p = 0.000076), with marked improvement in 9 of 14 cases and moderate improvement in 5 (37). These surgical studies did not measure investing fascial stiffness, nor did they use SWE to confirm that the structure released was the investing fascia itself; the specific anatomical extent of “release” or “carotid sheath opening” may differ among surgeons. They at least demonstrate, however, that release interventions targeting perisheath soft tissue are clinically feasible and that their additional benefits are consistent with the direction of the hypothesis that “soft-tissue constraint is independent of bony constraint.”

Comparative evidence on intervention strategies supports the view that “upstream decompression may be superior to bypass alone.” The narrative review by Pang et al., summarizing 17 studies, showed that the overall outcome success rate of styloidectomy (79%) was superior to that of angioplasty/stenting (66%), and no complications were recorded in the surgical cases; the authors also noted that large cohort studies comparing surgical and endovascular interventions for IJVS are currently lacking (46). The 2025 review by Petersingham et al. further confirmed that surgical management of cervical IJV compression has not been standardized and that published outcome data are extremely limited; the 14 studies remain predominantly case reports and small single-center cohorts, and although styloidectomy was the most common procedure (124 cases), complications and symptom recurrence occurred in 13 cases (41). This provides a reference at the review level for the hypothesis that “treatment selection should be based on the combined phenotype rather than on a single anatomical degree of stenosis,” and also confirms from the clinical strategy side the evidence gap of “absence of randomized controlled trials of targeted intervention.”

Manual interventions targeting the cervical mechanical environment can be standardized in RCTs and are accompanied by improvement in flow indicators. The randomized controlled trial by Uzun et al. showed that cervical mobilization combined with clinical Pilates exercises can improve pain and muscle stiffness and can improve head and neck blood flow in patients with cervicogenic headache (38). The RCT by Raja et al. further advanced the intervention target to the deep cervical fascia itself: among 99 patients with mechanical neck pain, deep cervical fascial manipulation combined with sequential yoga poses, compared with usual care, produced a between-group NPRS difference of −1.701 (p < 0.001), an elbow extension range-of-motion difference of 20.120 degrees (p < 0.001), and an FABQ difference of −5.036 (p < 0.001) at the fourth follow-up visit (39). The outcomes of that RCT were pain and function; IJV flow parameters and investing fascial stiffness were not measured, and the intervention target was the deep cervical fascia rather than the anterolateral segment of the investing fascia; its value lies in confirming, through an RCT design, that “fascial manipulation as an intervention category” can be standardized and executed under randomized controlled conditions and can produce measurable between-group differences, thereby providing a transferable methodological template for the paired-endpoint design of Prediction 3. Beyond RCT evidence, an earlier human comparative study provided preliminary hemodynamic data for “manual intervention can directly alter IJV compression status”: Mandolesi and Ricci, in 26 subjects with complete (white) compression of at least one IJV in the forward neutral cervical posture, used ultrasound Doppler to evaluate IJV status before and after a single RIMA cervical manipulation and found that the total number of white compressions decreased from 32 sides to 6 sides (a reduction of 81.25%), with restoration of flow (40). This study had a small sample size (n = 26), no control group, and assessed only immediate effects; it did not measure investing fascial stiffness or symptom change and did not stratify the source of compression (fascial/muscular/bony); the authors themselves also stated that there is a “complete lack of similar scientific studies capable of confirming these data.” The value of this evidence lies in confirming with published human data the hemodynamic reversibility by which “manual intervention can restore IJV from complete obstruction to flow patency,” thereby providing a preliminary feasibility anchor for the “relief of upstream constraint→improvement in flow parameters” of Prediction 3; however, its intervention target is not equivalent to the investing fascia claimed by the hypothesis, and whether its effect is mediated through changes in fascial mechanics has not been tested. The above RCTs and comparative studies jointly suggest that, under an RCT design or a before–after design, interventions targeting the cervical mechanical environment can be accompanied by measurable improvements in head and neck blood flow indicators or fascia-related clinical outcomes.

6.9. Methodological Prerequisites and Operational Boundaries

The methodological prerequisites are already preliminarily available, and the operational boundaries are defined as follows. Fascial stiffness can be quantified by shear-wave elastography; Zandi et al. reported a test–retest reliability of cervical fascial stiffness of ICC(3,1) ≥ 0.90 and a reliability of thickness and stiffness ratio of ICC ≥ 0.80 (33); Liao et al. reported that the reliability of nuchal fascial SWE was moderate to excellent and that the forward head posture itself significantly alters the measured fascial stiffness (20). This elevates “postural control” from a design suggestion to an unavoidable methodological prerequisite for Prediction 1. Patra et al. further suggested that muscle contraction status itself is also an independent factor influencing IJV area (15)—future measurement protocols may need to simultaneously control cervical posture and the contraction status of the target muscle. Doppler ultrasound assessment of the internal jugular vein diameter ratio during the Valsalva maneuver and of J2 segment luminal collapse during inspiration constitutes an operationalization tool for collateral compensation and valvular function (11). On the basis of the above methodological prerequisites, the ROI localization of SWE measurement of the anterolateral segment of the investing fascia itself constitutes an independent methodological variable. The following measurement protocol is prespecified in the design of Prediction 1: (a) using the sternocleidomastoid muscle as a landmark, ROIs are placed separately at the superficial aspect of the muscle belly (where the investing fascia covers it) and at the deep surface of the muscle belly and the superficial aspect of the anterolateral sheath wall; (b) the sternocleidomastoid muscle belly is used as an internal reference to calculate a fascia/muscle stiffness ratio, so as to partially correct for the influence of muscle contraction status; and (c) inter-rater agreement in ROI localization is reported as a prerequisite indicator of the reproducibility of this measurement. This protocol cannot fully resolve the anatomical overlap between the investing fascia and the sternocleidomastoid muscle, but it can transform “overlap” from an uncontrollable anatomical confounder into a measurable internal reference—a logic consistent with the fascia/subcutaneous fat stiffness ratio reported by Zandi et al. as a reliability indicator (33). No human study has yet directly measured the stiffness of the anterolateral segment of the investing fascia and paired it with IJV flow parameters. The data of Zandi and Liao derive from the posterior cervical fascia and the nuchal fascia, respectively, rather than from the investing fascia–specific segment; they therefore represent the closest references for reliability and postural effects rather than direct precedents. Dapper et al. provided a magnitude reference for increased stiffness of fibrotic fascia, but their fibrosis was radiation-induced and the site was the cervical fascia as a whole (32). In addition, existing planar SWE models generally treat perisheath tissue as a homogeneous medium. The mechanical environment of the carotid sheath region, however, is multilayered and heterogeneous. Mechanical modeling of perisheath coupling therefore still requires refinement. This measurement difficulty is not unsolvable. Methodological work on jugular vein guided-wave elastography has proposed that incorporating the influence of perivascular soft tissue and prestress into the mechanical model is a necessary condition for inverse estimation of in vivo venous elastic properties, and has validated the feasibility of this inverse estimation pathway in phantoms and in vivo experiments (47). This methodological direction is consistent with the hypothesis’s need for “refinement of perisheath coupling modeling,” but its measurement object is the venous wall rather than the investing fascia, and it does not provide paired data with IJV compensatory indicators; therefore, it does not constitute filling of the core gap but merely suggests a possible technical pathway for future measurement protocols.

7. Relationship to the Multi-Pathway Superposition Framework and Pathway Localization

This hypothesis can be positioned within the investing fascia–carotid sheath multifactorial superposition framework. That framework positions investing fascial fibrosis as an upstream mechanical driver, the carotid sheath as an anatomical hub in which multiple structures coexist within a single sheath, and lists arterial, venous, lymphatic, sympathetic, and vagal downstream pathways. The task of the present hypothesis is to extract the causal structure from the venous pathway of that framework and to elevate it to a testable object centered on “whether collateral compensation and valvular function are adequate.” It does not claim that the venous pathway is the only or dominant pathway, but rather asserts that, within the venous pathway, the chain of investing fascial fibrosis→inadequate compensation→fluctuating elevation of intracranial venous pressure has testability independent of other pathways and cross-disease phenotypic explanatory power.

The positioning of the present hypothesis relative to the multi-pathway superposition framework is currently manifested mainly as the independent testability of the causal structure within the venous pathway, rather than as a specific elaboration of the interaction mechanisms between the venous pathway and other pathways (arterial, lymphatic, sympathetic/vagal). The latter—for example, the effect of altered sympathetic tone on IJV valvular function and the contribution of impaired lymphatic return to intrasheath pressure—are acknowledged as parallel pathways within the framework of the present hypothesis, but their quantitative interaction with the core chain of the present hypothesis still requires dedicated study. The boundary of the present hypothesis lies in the following: it asserts that the chain of “investing fascial fibrosis→inadequate compensation→fluctuating elevation of intracranial venous pressure” within the venous pathway has testability independent of other pathways, rather than asserting that this chain is sufficient to explain all clinical phenotypes of the multi-pathway superposition framework. This boundary statement also means that falsification of the present hypothesis pertains only to the mediation proposition within the venous pathway and does not constitute overall falsification of the multi-pathway superposition proposition of that framework.

8. Testable Predictions

8.1. Prediction 1: Association

After controlling for age, BMI, cervical posture (stretch vs. neutral), target muscle contraction status, and degree of bony compression, cervical spine imaging indicators of C1 anterior displacement/ligamentous laxity are included as competing explanatory variables in the covariate set, so as to statistically distinguish fascial mediation from ligamentous mediation. Under these conditions, investing fascial SWE stiffness is independently associated with core compensation indicators during IJV outflow obstruction—the Valsalva diameter ratio and the cross-sectional area of the nonjugular drainage system. These two indicators are designated as core because neither is definitionally equivalent to “external constraint”: the Valsalva diameter ratio captures the functional recruitment of venous reserve under load, and the nonjugular drainage system area captures the anatomical substrate of collateral compensation. J2 inspiratory collapse is retained as a downstream marker of external constraint and is analyzed in a separate link—the association between investing fascial stiffness and J2 inspiratory collapse tests whether the upstream fascial variable is linked to the downstream imaging expression of external constraint, but it does not serve as the core test of the mediation proposition. This separation avoids the circularity that would arise if an indicator definitionally downstream of external constraint were used as the primary evidence for the compensation-mediation pathway. The Valsalva diameter ratio and nonjugular drainage system area are therefore the prespecified core indicators for the falsification logic of Prediction 1; J2 inspiratory collapse is a prespecified secondary indicator for the upstream→marker link. Liao et al. showed that forward head posture significantly alters nuchal fascial stiffness (20); cervical posture during measurement is therefore a prespecified control variable. Patra et al. showed that omohyoid contraction alters IJV area (15); the contraction status of the target muscle is also a control variable. Otherwise, muscular constraint may become an unmeasured confounder. With respect to measurement of investing fascial SWE stiffness, an ROI localization protocol using the sternocleidomastoid muscle as an anatomical landmark is adopted: ROIs are placed separately at the superficial aspect of the muscle belly (where the investing fascia covers it) and at the deep surface of the muscle belly and the superficial aspect of the anterolateral sheath wall, and a fascia/muscle stiffness ratio is calculated using the sternocleidomastoid muscle belly as an internal reference; inter-rater agreement in ROI localization is reported. This protocol cannot fully resolve the anatomical overlap between the investing fascia and the sternocleidomastoid muscle, but it can partially convert the confounder of “target muscle contraction status” into a measurable internal reference; residual overlap is declared as a limitation in interpretation of results rather than regarded as having been separated. The logical relationship between the fascia/muscle stiffness ratio and the muscle contraction covariate is specified to avoid the appearance of redundancy. The ratio operates at the within-subject measurement level: it expresses the stiffness of the fascial layer relative to the muscle belly in the same individual at the same measurement session, thereby partially correcting for the absolute stiffness inflation caused by muscle contraction. The muscle contraction covariate operates at the between-subject analysis level: it accounts for residual between-subject differences in contraction status that may alter the fascia–muscle relative relationship itself. For example, if contraction disproportionately stiffens the muscle belly relative to the fascia, the ratio may shift systematically across individuals with different baseline contraction states. The two are therefore complementary rather than redundant: the ratio reduces within-subject confounding, and the covariate addresses between-subject residual confounding of the ratio. Both are prespecified in the analysis plan, and the rationale for retaining the covariate despite ratio correction is stated explicitly rather than left implicit. If the ratio and the muscle contraction covariate are highly collinear in the pilot data (e.g., |r| > 0.7), the prespecified analysis plan prioritizes the ratio as the primary measure and treats the covariate as a sensitivity analysis rather than including both simultaneously in the same model. The collinearity threshold and the choice between these strategies are specified before data collection. Furthermore, Liao et al. have demonstrated that forward head posture itself can acutely alter nuchal fascial stiffness (20). Investing fascial stiffness may therefore not be a stable trait variable but may be state-dependent. When conditions permit, stiffness is measured in both the neutral position and a loaded position (e.g., forward head posture or Valsalva) to distinguish “baseline stiffness” from “load responsiveness”; the latter may be closer to the construct of “compensatory reserve.” If surgical or interventional treatment is used in the future, confirmation of “target engagement” includes both a decrease in target fascial SWE stiffness (prespecified criteria are given in Prediction 3) and intraoperative confirmation that the release plane lies between the sternocleidomastoid muscle and the IJV—the latter being a direct test of the operationalization strategy in Section 3; the directional concordance criterion specified in Section 3 (a higher stiffness value at the anterolateral sheath wall segment than at a control fascial site not continuous with the sheath, or intraoperative confirmation that the release plane corresponds to the ROI-localized layer) is applied as the anatomical reference for this confirmation. In addition, the connective tissue disease coexisting phenotype described by Midtlien et al. suggests that a history of connective tissue disease or related clinical indicators may be included as covariates of upstream susceptibility in the model for Prediction 1 (21). The reduction in IJV cross-sectional area at the C1 level observed by Hauser et al. in the hEDS population suggests that cervical segmental imaging indicators may be included in the same covariate framework (22).

8.2. Prediction 2: Effect Modification (Core Test)

The association between investing fascial stiffness and symptoms is modified by collateral compensatory capacity or by the cross-sectional area of the nonjugular drainage system. The association is significant in the subgroup with inadequate compensation and attenuated or nonsignificant in the subgroup with adequate compensation. This prediction directly distinguishes between two models—“collateral compensation and valvular function are mediators” versus “stenosis itself is the cause”—and its a priori plausibility derives from the protective effect of severe vertebral vein dilation observed by Han et al. (OR = 0.184) (1) and from the difference in nonjugular system volume observed by Pardo et al. (14). Sample size and statistical power considerations for the core effect-modification test are prespecified. As a framework for power estimation, detecting a moderate interaction effect at 80% power and a two-sided α of 0.05 requires approximately 200–300 participants with complete data on fascial stiffness, compensation status, and symptoms. This estimate assumes an interaction odds ratio of approximately 2.0 for the joint effect of high fascial stiffness and inadequate compensation (compared with the main effects alone), a 1:1 ratio of adequate to inadequate compensation, and a symptom prevalence of 40–60% in the inadequate-compensation subgroup. It is illustrative and is to be refined in a pilot study that provides empirical estimates of the variance of the interaction term and the correlation between fascial stiffness and compensation indicators. If the interaction effect is smaller (e.g., an interaction odds ratio of 1.5), the required sample size increases substantially (approximately 600–800 participants), which may necessitate a multicenter design or the use of continuous symptom outcomes to increase power. These estimates are provided as a starting framework rather than as definitive sample-size calculations; their purpose is to make explicit that the core discriminatory test of Prediction 2 has non-trivial sample-size requirements that are addressed at the design stage. Supplementary (non-core): valvular function (retrograde flow during Valsalva) may be included as a second effect dimension in the same model for exploratory testing; if its modifying effect exists independently of collateral compensation, this would support the positioning of a “parallel effect dimension”; if it manifests only when coexisting with inadequate compensation, this would suggest an additive model. In addition, the individual differences in perisheath fascial layer thickness/degree of fusion described in Section 3 (4) may be included as another candidate modifying variable in the same exploratory framework: if the association between “investing fascial stiffness→symptoms” is stronger in individuals with thicker or more densely fused perisheath fascial layers, this would support “stress transmission efficiency” as an effect-modifying mechanism. This analysis does not bear the core function of Prediction 2 in distinguishing “compensation as mediator” from “stenosis as cause,” and therefore does not alter the falsification status of Prediction 2. This supplement is consistent with the parallel effect dimension declaration of Subproposition C, and together they define the non-core testing status of the valve in this framework.

8.3. Prediction 3: Intervention Reversibility

After release of the investing fascia and the fascial layer continuous with the carotid sheath, improvement in IJV flow parameters shows paired changes with symptom improvement. Available feasibility anchors include the following. First, surgical decompression studies: Abeysinghe et al. reported paired improvement in IJV stenosis grade and headache after combined styloidectomy + IJV fasciotomy + C1 transverse process resection (Δ stenosis grade = 1.89, Δ headache = 1.85) (34); Lu et al. reported additional symptom benefit (62.5% vs. 20%), stenosis relief (84.3% vs. 46.67%), and hemodynamic improvement (75% vs. 40%) of C1 transverse process resection combined with soft-tissue release compared with bony decompression alone (35); Suri et al. reported a postoperative decrease in the maximum flow velocity gradient point (median −36.9 cm/sec), with the maximum gradient point most often located between the sternocleidomastoid muscle and the carotid bulb (36); and Aghayev et al. listed “carotid sheath opening” as an independent step, after which IJV cross-sectional area doubled (37). Second, muscular release studies: Simka and Gianesini reported complete restoration of IJV outflow after simple muscle transection for omohyoid compression (6–7); and Cha et al. reported symptom relief after surgical or neurotoxin release of vertigo and headache caused by compression of the IJV by the sternocleidomastoid/omohyoid complex (16). Third, manual therapy and RCT evidence: Uzun et al. showed improvement in head and neck blood flow accompanying cervical mechanical intervention (38); Raja et al. showed a measurable clinical effect of deep cervical fascial manipulation under randomized controlled conditions (39); and Mandolesi and Ricci reported preliminary hemodynamic reversibility in which RIMA cervical manipulation reduced IJV white compression from 32 sides to 6 sides (a reduction of 81.25%) (40). The key design feature is to use flow parameters and symptoms as paired endpoints and to include a sham-surgery or standard-treatment control. A critical biological premise of Prediction 3—fibrotic remodeling must be at least partially reversible for mechanical release to restore fascial elasticity—is explicitly acknowledged as an assumption that has not been directly tested in the investing fascia. It is unknown whether the chronic, posture- and inflammation-driven fibrosis of the investing fascia is reversible. It is also unknown whether simple mechanical release is sufficient to initiate reversal, or whether concurrent biological interventions (e.g., anti-inflammatory or antifibrotic strategies) are required. If investing fascial fibrosis proves to be largely irreversible once established, Prediction 3 may hold only for the subset of patients in whom the dominant constraint is muscular or acutely reversible fascial tension rather than established collagenous fibrosis; this would constitute an important boundary condition for the intervention prediction, and future studies should include histological or imaging markers of fibrosis reversibility (e.g., SWE stiffness reduction, collagen turnover biomarkers) as candidate effect modifiers. The operational criterion for “target engagement” is prespecified as a design prerequisite: a ≥20% decrease in target fascial SWE stiffness from before to after intervention is used as the preset minimum criterion (or “a decrease to within 1 standard deviation of the healthy control mean” is used as an alternative criterion). A 20% threshold is merely a preset value pending calibration in a pilot study and is not a validated cutoff; the pilot study reports measurement error and physiological fluctuation, and if these approach that magnitude, the threshold is raised or the alternative criterion used. Participants who do not meet this criterion are handled as a prespecified stratification variable in the analysis rather than merged with those who do. The findings of Patra et al. further suggest that the “target” may not be limited to the investing fascia itself but may also include specific muscle structures directly adjacent to the IJV pathway (e.g., the omohyoid muscle) (15); the cases of Simka, Gianesini, and Cha demonstrate that targeted transection or release of such muscular constraints can achieve complete restoration of IJV outflow or symptom relief within weeks after surgery (6–7,16). Future intervention designs may need to distinguish “fascial constraint” from “muscular constraint.” To this end, an operational discrimination pathway between “investing fascia-specific release” and “carotid sheath opening” is proposed. The pathway comprises three levels: (a) at the preoperative assessment level, patients with high investing fascial SWE stiffness but without imaging evidence of muscular or bony compression are classified as candidates for fascia-specific release, whereas patients with imaging evidence of muscular compression (e.g., omohyoid or sternocleidomastoid hypertrophy or anomalous insertion) or bony compression (e.g., elongated styloid process or C1 transverse process encroachment) are classified as candidates for combined or bony decompression; (b) at the intraoperative confirmation level, the release plane is verified to lie between the sternocleidomastoid muscle and the anterolateral sheath wall (fascia-specific release) rather than simply opening the sheath (carotid sheath opening)—the latter may not address the extrasheath fascial constraint that the present hypothesis implicates; (c) at the postoperative verification level, a decrease in investing fascial SWE stiffness (as specified above) is documented alongside flow improvement, so that the specificity of the intervention can be assessed. This discrimination pathway is an operationalization proposal, not a validated algorithm; its value lies in making the distinction between “fascial release” and “sheath opening” an executable and testable design feature rather than a semantic ambiguity. Two boundaries also apply. First, there is currently no controlled trial using investing fascial SWE stiffness as the exposure and IJV flow parameters as paired endpoints; “release,” “fasciotomy,” or “carotid sheath opening” in surgical studies has not been confirmed by SWE to release the investing fascia itself (34–35,37); and the study of Mandolesi and Ricci did not measure investing fascial stiffness or paired symptom change (40). Second, whether the intervention truly reduces target fascial SWE stiffness is a prerequisite for interpreting negative results—otherwise, a negative result cannot distinguish “the hypothesis is wrong” from “the intervention did not engage the target.”

8.4. Prediction 4: Discriminative Value and Mechanistic Explanation of “Incomplete Response”

In patients undergoing decompression for bony compression, postoperative outcome is modified by preoperative investing fascial stiffness. The controlled data of Lu et al. (combined soft-tissue release 62.5% vs. bony decompression alone 20%) have already suggested from the intervention side that “an independent soft-tissue constraint component exists in addition to bony decompression” (35); the present prediction further asserts that the strength of this soft-tissue constraint component can be quantified by preoperative investing fascial SWE stiffness. A phenomenon that the hypothesis must positively explain is the following: after IJVS stent placement, headache and tinnitus improve significantly in the short term, whereas visual loss and papilledema do not improve significantly in the short term, and the latter also gradually improve during long-term follow-up (44). The data of Bai et al. show that this dissociated response occurs against a background in which both intracranial pressure and the pressure gradient decrease significantly; therefore, it cannot simply be attributed to “inadequate decompression.” The surgical cohort of Margraf et al. further shows that the magnitude of response of different symptoms to relief of the same upstream constraint is not uniform (45). The present hypothesis asserts that this “incomplete response” suggests that downstream phenotypes differ hierarchically in their sensitivity to restoration of compensation; likewise, residual headache or cognitive symptoms after bony decompression may reflect an unaddressed investing fascial constraint or downstream sensitization that has entered an irreversible stage.

9. Falsification Pathways and Boundary Delimitation

Falsification conditions: If Prediction 1 is null under the condition that the ROI validity preconditions specified in Section 3 have been met; if Prediction 2 shows no modification; if Prediction 3 shows a lack of paired correlation between flow improvement and symptom improvement (and the intervention did indeed reduce target fascial stiffness); or if Prediction 4 shows that preoperative fascial stiffness is unrelated to residual symptoms—if any one of these holds, the mediation proposition is substantially weakened. The qualification on Prediction 1 is not an exemption clause: it specifies that the falsifying weight of a null Prediction 1 result is conditional on the measuring instrument having passed its own prespecified validity gate, and that a null result obtained with an invalid instrument neither falsifies nor supports the mediation proposition.

Prediction–falsification–boundary correspondence. Prediction 1 tests whether investing fascial SWE stiffness is independently associated with IJV compensatory indicators after covariate adjustment; a null association would weaken the mediation proposition. Its main limitations are the anatomical overlap between the investing fascia and the sternocleidomastoid muscle and the fact that the ROI protocol remains to be validated. Prediction 2 tests whether collateral compensatory capacity modifies the fascial stiffness–symptom association; the absence of a modifying effect would weaken the mediation proposition. Its main limitations are that valvular function is examined only as a parallel exploratory dimension and that perisheath fascial thickness is a candidate modifying variable rather than a confirmed one; sample size requirements for the interaction test are non-trivial and have been addressed in the prediction statement. Prediction 3 tests whether IJV flow and symptoms improve in a paired manner after fascial release; a lack of paired correlation between flow improvement and symptom improvement—provided the intervention did indeed reduce target fascial stiffness—would weaken the mediation proposition. Its main limitations are that existing surgical studies have not confirmed the target by SWE, that the 20% threshold remains to be calibrated, and that the reversibility of established fascial fibrosis is an untested premise. Prediction 4 tests whether preoperative fascial stiffness modifies residual symptoms after bony decompression; if preoperative fascial stiffness is unrelated to residual symptoms, the mediation proposition would be weakened. Its main limitations are that downstream phenotypes may have entered an irreversible stage and that symptom dimensions differ in responsiveness.

Boundary One: It is not claimed that investing fascial fibrosis is the sole upstream cause. Bony compression, intraluminal lesions, and thrombotic factors can independently cause disease; soft-tissue compression is often designated in the literature as compression by the sternocleidomastoid muscle or the common carotid artery, and the designation of the investing fascia as an independent variable remains a claim of the present hypothesis rather than an established consensus (5). “IJV fasciotomy,” “release,” or “carotid sheath opening” in surgical studies has likewise not been confirmed histologically or by SWE to release the investing fascia itself (34–35,37); the manual intervention of Mandolesi and Ricci also did not measure investing fascial stiffness (40).

Boundary Two: It is not claimed that all inadequate compensation originates from the investing fascia. Collateral compensatory capacity is influenced by congenital variation and age; the volume of the nonjugular drainage system may be a structural variable independent of fascial status (14). The connective tissue disease coexisting phenotype suggests that inadequate compensation in some patients may be set against a background of systemic connective tissue fragility rather than caused solely by local fascial fibrosis (21–22).

Boundary Three: It is not claimed that relieving fascial constraint will necessarily cure symptoms. Long-standing elevation of intracranial venous pressure and impaired glymphatic clearance may already have entered a self-reinforcing pathological stage (28), and relief of the upstream mechanical constraint may only reduce the rate of progression or the symptom threshold. Furthermore, the reversibility of established investing fascial fibrosis—the biological premise that mechanical release can restore fascial elasticity—is not established. If collagenous fibrosis has progressed beyond a reversible threshold, mechanical release may improve flow only to the extent that it relieves the residual elastic tension of the non-fibrotic fascial component, and the symptom benefit may be correspondingly limited. The effectiveness of intervention depends on whether it targets an identified compression target and actually alters the mechanical state of the target fascia, rather than being predicated on the “category of manual technique” itself.

Boundary Four: It is not claimed that a causal relationship between investing fascial fibrosis and inadequate compensation has been established. The above gaps are not equivalent in nature and are stratified into three tiers. The measurement-validity tier—whether the ROI protocol meets prespecified validity criteria—is a precondition to be evaluated before Prediction 1 can bear falsifying weight; if the protocol fails these criteria, Prediction 1 is classified as “measurement not yet ready” rather than “hypothesis falsified.” The measurement-feasibility tier—the feasibility of SWE measurement of the anterolateral segment of the investing fascia—is already methodologically feasible: the ROI localization protocol using the sternocleidomastoid muscle as a landmark described in Section 3 and Prediction 1 can be executed with existing equipment, and its inter-rater agreement is itself a reportable methodological output. The paired-validation tier—paired analysis of investing fascial stiffness with IJV flow parameters—is the true core to be filled; its resolution does not depend on new technology but on prospective execution of ROI standardization, measurement validity gate evaluation, and measurement condition control. This stratification has direct implications for the falsification logic. First, the null hypothesis test of Prediction 1 can be initiated under current methodological conditions without awaiting the advent of a “perfect measurement tool.” Second, if the ROI protocol passes its prespecified validity criteria and Prediction 1 remains null, the weakening of the mediation proposition cannot be exempted on the grounds of “imperfect measurement.” Third, if the protocol fails its validity criteria, the null result neither falsifies nor supports the mediation proposition; the hypothesis then remains in a “pending measurement validation” state rather than being either confirmed or exempted. In addition, soft-tissue decompression techniques remain inadequate, and the ability of existing planar SWE models to model the multilayered coupled mechanical environment around the sheath still requires refinement. Although methodological directions such as guided-wave elastography suggest a technical pathway that incorporates perisheath soft tissue and prestress (47), and although Dapper et al. provide a magnitude reference for increased stiffness of fibrotic fascia (32), their measurement objects are the venous wall and the cervical fascia as a whole, respectively, and neither can substitute for direct measurement of the anterolateral segment of the investing fascia. The connective tissue disease coexisting phenotype of Midtlien et al. provides a clinical entry point for upstream susceptibility (21), and the hEDS imaging data of Hauser et al. localize this susceptibility to the carotid sheath level (22), but neither measured investing fascial stiffness and thus neither fills the core gap.

10. Related Diseases and Clinical Phenotypes: Venous Outflow–Related Phenotypes Within the Same Mechanical Framework

This hypothesis does not attempt to attribute the following diseases to a single mechanism; rather, it points out that the chain of investing fascial fibrosis→inadequate compensation of IJV outflow provides a common upstream mechanical entry point for understanding venous outflow obstruction–related phenotypes in these diseases. The entries are grouped by distance of association from the core chain: Group A comprises diseases with relatively direct association with IJV stenosis and relatively concentrated evidence in the literature; Group B comprises clinical phenotypes that occur at high frequency in the IJV stenosis population but still require independent validation as “syndromes”; and Group C comprises an extended spectrum with more distal association, stronger mechanistic inference, and the need for the most cautious wording. The evidence and limitations for each entry have been summarized in the evidence-grading paragraphs of Section 6 and are not restated entry by entry here.

10.1. Group A: Disease Entities with Relatively Direct Association with IJV Stenosis

Headache associated with IJV stenosis. The 283-case dataset constitutes the most direct clinical anchor—the protective effect of severe vertebral vein dilation suggests that headache risk in this population depends more on collateral compensation (and the parallel valvular dimension) than on stenosis itself (1). The significant improvement in headache and tinnitus after stent placement supports the directionality of “relief of constraint→symptom improvement” from the intervention side, but the limited short-term effect on papilledema suggests that sensitivity differs among downstream phenotypes (44); this pattern is addressed in Prediction 4. The CFD analysis of Li et al. further suggests from the fluid mechanics side that the hemodynamic consequences relevant to headache may depend on the stenotic segment and the source of compression rather than on the stenosis percentage alone (8).

Eagle jugular syndrome and IJV compression syndrome. Bony compression at the styloid process–C1 transverse process region is a recognized etiology, but the efficacy of bony decompression is not complete. Zamboni et al. compared the jugular variant of Eagle syndrome with the classic/carotid variant and found that headache was a more prominent symptom in the jugular variant (p < .009) and was more significantly associated with peri-midbrain hemorrhage (17). The systematic review by Tadjer and Béjot further confirmed that IJV stenosis is the most common vascular complication in the vascular variant of Eagle syndrome (28/56), followed by internal carotid artery dissection (18). The present hypothesis asserts that soft-tissue constraint originating from the investing fascia may constitute an upstream mechanical mechanism of soft-tissue compression and may exert additive effects with bony compression. The controlled data of Lu et al. provide direct intervention-side support for the position that “an independent soft-tissue constraint component exists in addition to bony decompression” (35). The multi-position CTV data of Jiang et al. further show from the dynamic imaging side that, in patients with ESP, severe IJV compression states consist predominantly of muscle–muscle and muscle–vessel compression, with bone–bone compression accounting for only a minority (25). Their reported perioperative fatal case in a patient with bilateral ESP further suggests that when bilateral compensation is simultaneously exhausted, IJV outflow obstruction can lead to catastrophic consequences (25). The 223-case dynamic venographic pressure series of Ashraf et al. further revealed a segmentally dependent stenosis pattern at the C1 level (contralateral head rotation) and the C2–4 level (ipsilateral head rotation) (13). The presence of residual symptoms after bony decompression is not a falsification of “bony etiology” but rather a suggestion that “bony etiology may not be the sole source of constraint.”

Ménière disease. The prospective study by Filipo et al. showed that the proportion of IJV stenosis with hemodynamic alterations was significantly higher in patients with Ménière disease than in controls, and intracranial venous reflux was also significantly enriched; the authors accordingly proposed that venous stasis may be a further pathogenic mechanism of Ménière disease (48). Within the framework of the hypothesis, Ménière disease can be regarded as a downstream expression of “IJV outflow obstruction→venous shunting to the inner ear drainage territory.”

Transient monocular blindness (TMB). Cheng et al. found that in TMB patients without carotid artery stenosis, the proportions with significant compression of the upper and middle segments of the IJV were both significantly higher than in controls; the authors suggested that IJV compression leads to impaired cerebral venous outflow and ocular venous hypertension, the latter being one cause of TMB (49). This is consistent with the logic of the hypothesis that “venous pressure is transmitted upstream to the ocular venous system.”

Multiple sclerosis (MS)—the need to distinguish “association” from “causation.” The association between IJV stenosis and MS has been repeatedly reported in the literature, but the hypothesis of CCSVI as the cause of MS has not been supported. Within the framework of the present hypothesis, MS should not be listed as a “disease caused by IJV stenosis” but should be positioned as follows: in patients with MS, if IJV stenosis coexists, that stenosis may act as a modifiable mechanical comorbidity dimension contributing to symptom burden (particularly fatigue and autonomic symptoms), rather than as the cause of MS. The restoration of outflow after surgical relief of omohyoid compression of the IJV reported by Simka et al., and the coexistence of IJV stenosis with autonomic symptoms reported by Sternberg et al., both support this cautious positioning (6,50).

Alzheimer disease (AD) and cognitive decline. The prospective study by Adachi et al. showed that severe jugular venous reflux was associated with lower baseline cognitive scores and with incident dementia during follow-up (29). Pardo et al. showed from the structural side that total venous cross-sectional area and nonjugular drainage system volume were significantly smaller in cognitively impaired individuals (14). The review by Eliav et al. provides a mechanistic interface: a positive feedback loop in which venous insufficiency→impaired glymphatic clearance→β-amyloid accumulation→further venous damage (28). The review by Hui et al. confirms from the clinical side that cognitive impairment is increasingly recognized in patients with cerebral venous congestion, but the source of symptom heterogeneity remains an unresolved question, and existing cognitive assessment tools are insufficiently sensitive to venous impairment (2). Yin et al. provide an effect size from the functional operational side: impaired internal jugular venous drainage, defined as TAMV < 4 cm/s or J2 inspiratory collapse, was significantly more prevalent in the cognitively impaired group (11). Together, these lines of evidence extend “collateral compensation and valvular function” from a mediating concept for explaining headache to a variable associated with cerebral clearance function and long-term cognitive outcomes. The position of the present hypothesis here is cautious: it does not claim that investing fascial fibrosis is the cause of dementia, but rather asserts that, in cognitively impaired individuals with phenotypes related to venous outflow obstruction, the investing fascia–inadequate compensation chain may constitute a measurable upstream mechanical factor. The clinical study by Peng et al. on C1 transverse process resection for cognitive impairment caused by IJV stenosis suggests from the intervention side that relief of bony/soft-tissue constraint may produce measurable effects on cognitive symptoms, although the procedure was not confirmed by SWE to address investing fascial status (51).

10.2. Group B: Clinical Phenotypes Occurring at High Frequency in the IJV Stenosis Population

Insomnia. Bai et al. reported that the prevalence of insomnia in patients with IJVS was significantly higher than in the CVSS group; insomnia improved significantly in the short term after stent placement and was further “significantly reduced or even completely resolved” in the long term (44). This provides paired data on prevalence and intervention response for “IJV outflow obstruction→sleep disorder.” The mechanism of insomnia may involve nocturnal fluctuation of intracranial venous pressure and pressure effects on venous drainage territories of the brainstem/hypothalamus, but independent validation is still required.

Autonomic dysfunction (fatigue, temperature intolerance, bowel/bladder symptoms, blood pressure abnormalities). Sternberg et al. screened MS patients for “IJV stenosis combined with ≥3 autonomic dysfunction symptoms” and found that the vast majority of screened patients had both IJV stenosis and ≥3 autonomic symptoms; blood pressure showed a biphasic response after jugular venous balloon angioplasty—rising in those with lower baseline blood pressure and falling in those with higher baseline blood pressure—suggesting an intervenable association between IJV stenosis and autonomic regulation (50). Within the framework of the present hypothesis, autonomic symptoms can be localized to the sympathetic/vagal pathway of the investing fascia–carotid sheath hypothesis, in parallel with rather than subordinate to the venous mechanism. Framework attribution statement: this entry is included as a clinical manifestation of a parallel pathway (sympathetic/vagal) within this framework, to illustrate the breadth of the phenotype spectrum in the IJV stenosis population; its quantitative interaction with the venous chain is beyond the scope of testing in the present hypothesis and does not constitute support for the “investing fascia→inadequate compensation” chain. The high comorbidity burden of autonomic dysfunction (45.3%) and POTS (55.8%) in the connective tissue disease coexisting subgroup reported by Midtlien et al. further suggests that this phenotype may be set against a background of systemic connective tissue fragility (21).

Anxiety, depression, and brain fog/psychiatric symptoms. Hauser et al. reported in consecutive patients that the rate of reported brain fog was extremely high and that the vast majority had significantly reduced IJV cross-sectional area and elevated ONSD (suggesting increased intracranial pressure); in the lateral decubitus position with cervical collar support, the IJV cross-sectional area at the C1 level was significantly larger than in the supine position; the authors explicitly listed “compression of carotid sheath structures” as one of the potential causes of brain-derived symptoms (52). The introduction of ONSD provides a bedside-measurable surrogate indicator for “venous hypertension,” giving the mediating step of “inadequate compensation→elevated intracranial pressure” an operational anchor that is more readily obtainable in clinical research than lumbar puncture. The review by Hui et al. suggests that existing cognitive/psychiatric assessment tools are insufficiently sensitive to venous impairment and may underestimate the true burden of this phenotype (2). Within the framework of the hypothesis, this phenotype can be localized to the downstream effects of venous hypertension→altered cerebral perfusion/white matter changes→emotional and cognitive circuits. Margraf et al. reported that brain fog was the most frequent preoperative complaint (98.0%) and that symptom improvement after targeted surgery exhibited marked dimensional differences, providing a surgical-side anchor for the intervention responsiveness of this phenotype (45).

Pulsatile tinnitus and vertigo. Pulsatile tinnitus and vertigo often coexist as auditory and vestibular phenotypes of IJV outflow obstruction. Cha et al. reported persistent oscillating vertigo (POV) whose symptoms were associated with venous compression between the C1 transverse process and the styloid process, beneath the sternocleidomastoid muscle, or at the thoracic outlet; catheter venography showed dynamic obstruction with shunting of venous blood to the petrosal sinus (around the inner ear) and to the vertebral veins, and POV was significantly relieved after relief of compression; the authors concluded that venous outflow obstruction and elevated periauricular venous pressure can cause persistent peripheral stimulation of the vestibular system and downstream central effects (53). Cha et al. further reported a case series of 12 patients with vertigo and headache caused by compression of the IJV by the sternocleidomastoid/omohyoid complex, in whom symptoms were provoked by ipsilateral head rotation and flexion and were relieved after surgical or neurotoxin release (16). Within the framework of the hypothesis, vertigo is a downstream expression of “IJV outflow obstruction→elevated periauricular venous pressure→stimulation of the vestibular system.” It is also qualified by the fact that pulsatile tinnitus often coexists with IJV stenosis, yet a 2026 case–control study found no significant differences between patients with pulsatile tinnitus and controls in either the prevalence of IJVS (P = .19) or stenosis severity (P = .61) (54). This suggests that IJVS itself is insufficient to explain this phenotype and that collateral or valvular status may be a more discriminating variable. This negative/de-specificity result is directionally consistent with the position of the present hypothesis that “stenosis itself does not equal clinical consequence, and compensation status is the key mediator,” and it also indicates that phenotypic specificity should be interpreted cautiously when pulsatile tinnitus is included in the spectrum of phenotypes associated with IJV stenosis.

Facial pain. Chan et al. reported that in patients with unexplained facial pain, the side of pain was consistent with the side of IJV compression in most cases; after decompression treatment targeting IJV obstruction, pain improved significantly in most patients, but some patients still had intractable pain; the mechanism involves IJV compression leading to dilation of the superior petrosal sinus and shunting via the vertebral veins to the region of the spinal trigeminal nucleus (55). Within the framework of the hypothesis, facial pain is another expression, beyond headache, of the downstream effect of “activation of the trigeminovascular system”; moreover, “partially intractable pain” provides clinical corroboration for Prediction 4 that “some downstream phenotypes may have entered an irreversible stage.”

Exertional headache. The study by Doepp et al. showed that the proportion of IJV valvular insufficiency was significantly higher in patients with exertional headache than in controls, and retrograde flow always occurred on the dominant drainage side (10). Within the framework of the present hypothesis, exertional headache can be understood as follows: upstream investing fascial constraint has already placed IJV compensation in a marginal state, and valvular insufficiency then pushes this marginal state past the symptom threshold during the Valsalva maneuver.

10.3. Group C: Extended Spectrum—Diseases with More Distal Association and Stronger Mechanistic Inference

Cerebral venous sinus thrombosis (CVST). The study by Wu et al. showed that nonthrombotic IJVS may be a risk factor for CVT; patients with IJVS-CVT have distinct clinical and imaging features (56). Within the framework of the hypothesis, CVST is an extreme downstream event of “venous outflow obstruction→stasis→thrombosis” and, together with the chronic state of “inadequate compensation” in the hypothesis, belongs to different time scales of the same mechanical chain.

Cervical spondylotic IJV compression syndrome. Ding et al. formally proposed “cervical spondylotic IJV compression syndrome” as a new subtype of cervical spondylosis, confirmed that C1 transverse process and combined C1 + styloid process compression are the main sources of bony IJV compression, and described a nonspecific symptom spectrum consisting mainly of insomnia, head noise, tinnitus, and headache (57). Within the framework of the hypothesis, this syndrome provides another specific disease carrier for “posture/degeneration→external bony constraint,” and together with styloid-derived compression, it constitutes the etiological spectrum of external IJV compression. The theoretical narrative proposed by Hauser et al.—ligamentous cervical instability→anterior displacement of C1→IJV encroachment—provides a parallel structural-mechanical explanation mediated by ligamentous/bony displacement for this etiological spectrum (23).

Spontaneous spinal cerebrospinal fluid leak (CSFL). The matched case–control study by Manupipatpong et al. showed that among patients with spontaneous spinal CSFL who did not meet diagnostic criteria for idiopathic intracranial hypertension, the prevalence of IJVS was significantly higher than in age- and sex-matched controls; all CSFL patients with venous manometry data had at least a unilateral IJV pressure gradient (58). The authors further proposed that after sustained elevation of CSF pressure leads to CSFL, the lumbar puncture opening pressure may be falsely normalized—a mechanism suggesting that normal resting manometry does not equal adequate compensation, directionally consistent with the “load exposure” logic of the hypothesis. This study is clarified by the fact that it was an exploratory case–control design with n = 12, that controls were patients with cerebrovascular accidents rather than healthy individuals, and that it did not measure investing fascial status or collateral compensatory indicators. Its value lies in extending the downstream expression of IJV outflow obstruction from the intracranial compartment to the spinal CSF space, adding an example at a different anatomical level to the “extended spectrum” logic of Group C, rather than providing direct evidence for the core chain of investing fascia→inadequate compensation.

Transient global amnesia (TGA). The prospective case–control study by Cejas et al. showed that the prevalence of IJV valvular insufficiency was significantly higher in patients with TGA than in controls, with the right side more frequently affected; a contemporaneous editorial confirmed that this supports the venous congestion hypothesis of TGA and noted that approximately 25% of patients had normal valvular function, indicating that venous congestion is not the sole determining factor (59). Within the framework of the hypothesis, TGA is included in Group C not as a direct downstream component of the “investing fascia→inadequate compensation” chain but as an independent clinical example of “valvular insufficiency as a parallel effect-modifying dimension.” The proposed mechanism is valvular insufficiency→intracranial retrograde flow during Valsalva→hippocampal venous ischemia, sharing the valvular dimension mechanism with exertional headache. The finding that approximately 25% of patients had normal valvular function provides an independent clinical footnote for the discriminative logic of Prediction 4. This inclusion also suggests that the valvular dimension can participate in symptom expression independently of investing fascial constraint—precisely the clinical manifestation of “valvular function as a parallel effect dimension” in Subproposition C of Section 2, rather than direct support for the investing fascial chain. The common logic for placing TGA alongside CVST, cervical spondylotic compression syndrome, and spontaneous spinal CSFL in Group C is “more distal association or stronger mechanistic inference,” not “all being direct downstream components of the same chain”; the value of including these entries lies in illustrating the breadth of the spectrum of venous outflow obstruction–related phenotypes, rather than in providing direct evidence for the investing fascial chain.

10.4. Summary: Significance of Stratification by Distance of Association

The association of Group A diseases with IJV stenosis already has relatively concentrated clinical evidence (prevalence comparison in Ménière disease, compression severity comparison in TMB, and the headache phenotype of the jugular variant of Eagle syndrome), but “association” still needs to be distinguished from “causation,” with MS being the most typical cautionary example. Group B phenotypes (insomnia, autonomic symptoms, anxiety/depression/brain fog, pulsatile tinnitus and vertigo, facial pain) occur at high frequency in the IJV stenosis population, and some improve after relief of compression; elevated ONSD further provides a bedside-measurable surrogate indicator for “elevated intracranial pressure”; however, their status as independent “syndromes” still requires prospective validation, and the negative case–control result for pulsatile tinnitus suggests limited phenotypic specificity (54). Group C (CVST, cervical spondylotic compression syndrome, spontaneous spinal CSFL, and TGA) has more distal association or stronger mechanistic inference and is explicitly labeled in the hypothesis as an “extended spectrum” positioning to avoid excessive causal extrapolation. Group C is not internally homogeneous in logic but contains four different types of “distality”: CVST is a stasis–thrombosis type of distal downstream event of “venous outflow obstruction→stasis→thrombosis,” belonging to different time scales of the same mechanical chain as chronic inadequate compensation; cervical spondylotic IJV compression syndrome is a bony etiological carrier, providing a specific disease carrier for “posture/degeneration→external bony constraint,” with the ligamentous/bony displacement theoretical narrative of Hauser et al. serving as its parallel structural-mechanical explanation; spontaneous spinal CSFL is a cross-compartment pressure coupling, extending the downstream expression of IJV outflow obstruction from the intracranial compartment to the spinal CSF space and, through a controlled design, excluding IIH as a classical mediator; and TGA is an example of the parallel valvular effect dimension, included not as a direct downstream component of the investing fascial chain but as an independent clinical example of “valvular insufficiency as a parallel effect-modifying dimension.” The shared significance of the three groups lies in the following: the downstream expression of inadequate IJV outflow compensation is not unitary but presents as a continuous spectrum from functional symptoms to structural complications across different target organs along the venous pressure gradient.

11. Clinical Implications and Conclusions

Shift in assessment anchors. Current assessment of IJV outflow obstruction focuses on the imaging identification of luminal diameter and bony compression. The present hypothesis advocates a shift toward combined assessment of functional and anatomical indicators: investing fascial stiffness reflects the strength of the upstream mechanical constraint; the Valsalva diameter ratio and the cross-sectional area of the nonjugular drainage system reflect the responsiveness and anatomical substrate of downstream compensation, whereas J2 inspiratory collapse serves as a downstream marker of external constraint rather than as a core compensation indicator; valvular function reflects whether pressure fluctuations can be “kept outside the door”; and ONSD provides a bedside-measurable surrogate indicator of intracranial pressure (52). The naming of White Compression further suggests that normal resting imaging does not rule out complete obstruction under load—assessment must be performed under conditions capable of exposing the compensatory reserve (12). The 223-case dynamic venographic pressure series of Ashraf et al., with the largest sample to date, quantified the ubiquity of severe IJV stenosis and transstenotic pressure gradients under head rotation and neck flexion loads, providing an epidemiological-level reinforcing anchor for “dynamic assessment” (13). The data of Liao et al. suggest that cervical posture itself can significantly alter the measured fascial stiffness (20); the data of Patra et al. suggest that the contraction status of the target muscle is also an independent factor influencing IJV area (15); the data of Ersoy Karka et al. suggest that cervical hyperextension, a daily postural load, can acutely reduce IJV flow velocity (24); and the multi-position CTV data of Jiang et al. quantify from the dynamic imaging side the incidence of IJV compression under rotational load and the composition of soft-tissue sources (25)—assessment protocols must simultaneously standardize posture, muscle contraction status, and head-neck mechanical loading. In addition, (3) suggests from the ICP dimension that an ICP threshold is likewise inadequate as a single diagnostic anchor; the assessment framework should simultaneously incorporate symptoms, venographic morphology, and hemodynamics, rather than relying solely on static ICP or stenosis percentage. The connective tissue disease coexisting phenotype of Midtlien et al. suggests that a history of connective tissue disease and related systemic indicators should be included in the assessment dimension of upstream susceptibility (21); the reduction in IJV cross-sectional area at the C1 level observed by Hauser et al. in the hEDS population further suggests that cervical segmental imaging indicators may serve as candidate assessment indicators for mechanical constraint at the carotid sheath level (22).

Implications for treatment stratification. Within the framework of the present hypothesis and within the venous pathway, if clinical outcome depends more on collateral compensation and valvular function than on stenosis itself, treatment selection—fascial release, bony decompression, stent placement, or sequential combinations—should be based on the combined phenotype rather than on a single anatomical degree of stenosis. The invasive benefit for individuals with adequate compensation may be limited, whereas patients with inadequate compensation and high investing fascial stiffness may be precisely the population with potential benefit from upstream soft-tissue intervention. Abeysinghe et al. reported paired improvement in IJV stenosis grade and headache after combined styloidectomy + IJV fasciotomy + C1 transverse process resection (34). Lu et al. reported additional benefit of C1 transverse process resection combined with soft-tissue release compared with bony decompression alone (62.5% vs. 20%) (35). Together, these studies suggest from the intervention side that “adding soft-tissue release beyond bony decompression” has measurable clinical value. Suri et al. reported a postoperative decrease in the maximum flow velocity gradient point (median −36.9 cm/sec), with the maximum gradient point most often located between the sternocleidomastoid muscle and the carotid bulb (36); this supports from the hemodynamic side the judgment that “soft tissue and bony structures jointly constitute the compression site.” Aghayev et al. listed “carotid sheath opening” as an independent step, after which IJV cross-sectional area doubled (37), providing a “cleaner” surgical precedent than combined procedures for “opening the sheath itself can improve IJV geometry.” Simka and Gianesini demonstrated that targeted transection of a single muscular constraint—the omohyoid muscle—can achieve complete restoration of IJV outflow within weeks postoperatively (6–7). Cha et al. further established vertigo and headache caused by compression of the IJV by the sternocleidomastoid/omohyoid complex as a clinical entity relievable by surgery or neurotoxin release (16). The review by Pang et al. further showed that the outcome success rate of styloidectomy (79%) was superior to that of stent placement (66%), but large comparative studies are lacking (46); the 2025 review by Petersingham et al. confirmed that surgical management of cervical IJV compression has not been standardized and that published outcome data are extremely limited, with the 14 studies remaining predominantly case reports and small single-center cohorts (41). The limitations of stent placement support this stratification logic from the opposite side. Fargen et al. reported that after IJV stent placement, approximately 75% of patients reported improvement initially, but only 36% maintained durable improvement at a mean follow-up of 4.5 months, and the perioperative complication rate was 33% (60). Notably, 69% of patients in that cohort had a connective tissue disease background. This suggests that simply relieving luminal stenosis may be insufficient to reverse the depletion of compensation driven by upstream soft-tissue constraint, particularly in the subgroup with systemic connective tissue susceptibility. Together, these lines of evidence suggest that treatment stratification must distinguish “bony” from “soft-tissue” constraint. It must also further distinguish “fascial” from “muscular” constraint within soft tissue. It must ask not only “whether to intervene” but also “whether the intervention targets an identified compression target and actually alters the mechanical state of the target fascia.” The latter is to be a prerequisite for efficacy assessment rather than a post hoc explanation; the “≥20% decrease in SWE stiffness” prespecified in Prediction 3 may serve as an operational starting point for this prerequisite, although this threshold is merely a preset value pending calibration in a pilot study. The operational discrimination pathway between “investing fascia-specific release” and “carotid sheath opening” proposed in Prediction 3—preoperative classification by SWE and imaging evidence, intraoperative verification of the release plane, and postoperative documentation of fascial stiffness reduction—is incorporated into future surgical study designs as a design feature rather than left as a post hoc distinction. The surgical cohort of Margraf et al. suggests from the symptom-response side that after relief of the same upstream constraint, the magnitude of improvement in different symptoms is not uniform; treatment stratification and efficacy assessment should incorporate “symptom dimension” into the combined phenotype (45).

Conclusions. The present hypothesis places IJV outflow obstruction within the investing fascia–carotid sheath mechanistic framework, and its core claim can be summarized as follows: within the framework of the present hypothesis, clinical outcome depends more on whether collateral compensatory capacity (and the parallel valvular dimension) remains sufficient to maintain outflow than on the anatomical degree of stenosis itself. The protective effect of severe vertebral vein dilation observed by Han et al. in 283 patients with IJVS (OR = 0.184) provides the most direct clinical empirical starting point for this claim (1); Liao et al. demonstrated in humans that forward head posture can significantly increase nuchal fascial shear modulus, providing SWE evidence for the first link of Subproposition A (20); the Valsalva diameter ratio and the cross-sectional area of the nonjugular drainage system provide operational definitions for core compensation indicators, while J2 inspiratory collapse serves as a downstream marker of external constraint (11); White Compression, as an independently named clinical entity, confirms that fascial compression of the IJV can be missed on resting imaging and exposed only under load (12); and the 223-case dynamic venographic pressure series of Ashraf et al., with the largest sample to date, confirmed the ubiquity of severe IJV stenosis and transstenotic pressure gradients under head rotation and neck flexion loads (13). Anatomy and histology provide localization and continuity references for the mechanical pathway of “extrasheath fascia→intrasheath structures” (9,19); Patra et al. (15), Ersoy Karka et al. (24), Simka and Gianesini (6–7), and Cha et al. (16) supplement the status of soft-tissue constraint as an independent clinical entity from the physiological, acute-load, and muscular-release sides; Dincă et al. (5) and dynamic rotational CTV (25) confirm the multiplicity of soft-tissue compression sources and their dynamic patterns. On the intervention side, Abeysinghe et al. (34), Lu et al. (35), Suri et al. (36), Aghayev et al. (37), and the muscular-release cases (6–7,16) jointly suggest that targeted release of perisheath soft tissue can improve IJV stenosis and symptoms, and that soft tissue and bony structures jointly constitute the compression site. Pang et al. (46) and Petersingham et al. (41), however, suggest that surgical intervention has not yet been standardized and that the evidence is limited. The valvular dimension, as a parallel effect dimension, has clinical associations that are modified by phenotype (10,29–31); collateral compensation and cognitive/structural evidence (1,11,14) extend “adequacy of compensation” into a measurable combined anatomical–functional variable. At the methodological level, direct paired SWE measurement of the anterolateral segment of the investing fascia and controlled trials using this pairing as an endpoint remain the core gaps; the 20% threshold is merely a preset value pending calibration in a pilot study. The reversibility of established investing fascial fibrosis remains an untested biological premise, and the discrimination between “fascial release” and “carotid sheath opening” remains an operationalization proposal rather than a validated algorithm. The value of the hypothesis lies not in its having been proven but in its having been constructed as a testable, falsifiable proposition: through fascial stiffness measurement, compensatory phenotype stratification, and paired-endpoint intervention studies, it can be either supported or weakened.